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ABSTRACT  
   
Gene manipulation techniques, such as RNA interference (RNAi), 
offer a powerful method for elucidating gene function and discovery of 
novel therapeutic targets in a high-throughput fashion. In addition, RNAi 
is rapidly being adopted for treatment of neurological disorders, such as 
Alzheimer’s disease (AD), Parkinson’s disease, etc. However, a major 
challenge in both of the aforementioned applications is the efficient 
delivery of siRNA molecules, plasmids or transcription factors to primary 
cells such as neurons. A majority of the current non-viral techniques, 
including chemical transfection, bulk electroporation and sonoporation 
fail to deliver with adequate efficiencies and the required spatial and 
temporal control. In this study, a novel optically transparent biochip is 
presented that can (a) transfect populations of primary and secondary 
cells in 2D culture (b) readily scale to realize high-throughput 
transfections using microscale electroporation and (c) transfect targeted 
cells in culture with spatial and temporal control. In this study, delivery of 
genetic payloads of different sizes and molecular characteristics, such as 
GFP plasmids and siRNA molecules, to precisely targeted locations in 
primary hippocampal and HeLa cell cultures is demonstrated. In addition 
to spatio-temporally controlled transfection, the biochip also allowed 
simultaneous assessment of a) electrical activity of neurons, b) specific 
proteins using fluorescent immunohistochemistry, and c) sub-cellular 
structures. Functional silencing of GAPDH in HeLa cells using siRNA 
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demonstrated a 52% reduction in the GAPDH levels. In situ assessment of 
actin filaments post electroporation indicated a sustained disruption in 
actin filaments in electroporated cells for up to two hours.  Assessment of 
neural spike activity pre- and post-electroporation indicated a varying 
response to electroporation. The microarray based nature of the biochip 
enables multiple independent experiments on the same culture, thereby 
decreasing culture-to-culture variability, increasing experimental 
throughput and allowing cell-cell interaction studies. Further development 
of this technology will provide a cost-effective platform for performing 
high-throughput genetic screens. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 Introduction 
A recent report released by the World Health Organization 
estimates that around 1 billion people globally are affected by neurological 
disorders, ranging from migraines to epilepsy and dementia. A great 
number of these disorders, such as Alzheimer’s disease (AD), Parkinson’s 
disease (PD) and multiple sclerosis, severely impact the quality of life of 
the patients, rendering them incapable of doing most basic tasks, and 
ultimately costing patients their lives. To this day, the treatment options 
for central nervous system (CNS) disorders are very limited; therapies are 
mostly symptomatic and do not offer much improvement. Thus there is a 
critical need for novel therapeutic strategies that can target the CNS 
disorders at their root cause to offer a complete cure.  
A major challenge in developing successful therapies for 
neurological disorders is the sheer complexity of the nervous system in 
terms of its structure and function. The nervous system comprises of 
complex neural circuits that operate synergistically to perform the most 
basic and high level functions of life. Within each of the neurons that form 
the neural circuits, there are complex molecular pathways that control the 
functioning of neurons. Any disruption in the molecular pathways by 
environmental cues or genetic mutation(s) leads to disease manifestation. 
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A therapy that aims to completely cure a neurological disorder needs to 
intervene at the molecular level and/or the neural circuit level (Jain, 
2007). The ultimate goal of the research here is to deliver a technology 
that will enable such a therapy.  
 
1.2 Genetic underpinnings in CNS disorders 
In many disorders of the CNS, genetic components have been 
implicated in underlying pathogenic mechanisms. In certain neurological 
disorders, mutation(s) in a specific gene(s) has been identified as the 
fundamental cause of disease pathology. For instance, in Huntington’s 
disease, a mutation in the Huntington gene leads to gradual damage to 
specific areas of the brain (Boudreau et al., 2009). Another example of an 
inherent brain disorder is spinocerebellar ataxia (SCA) which is 
characterized by progressive loss in coordination of limb movement and 
speech. There are more than 7 types of SCA (type 1, 2, 3 6, 7, 12 and 17) 
caused by CAG repeat expansions occurring within a gene and thus 
disrupting the normal functioning of the protein (Manto, 2005).  
In neurological disorders with complex etiology such as Alzheimer’s 
disease (AD), several genes including amyloid precursor protein gene 
(APP), presenilin 1 and 2 genes (PS1, PS2), beta secretase (BACE1), 
apolipoprotein E (APOPE), and SORL-1 have been implicated and many 
more are currently being investigated for their role in the pathology and as 
potential therapeutic targets (Citron et al., 1997; Y. Luo et al., 2001; 
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Rogaeva et al., 2007; Strittmatter & Roses, 1995). Another example is 
Parkinson’s disease (PD), where point mutation in α-synuclein, a 
phosphoprotein enriched in presyanptic terminals, has been linked to 
pathogenesis of the disease (Sapru et al., 2006). Apart from the 
neurodegenerative disorders mentioned above, gene therapy is also 
amenable to brain tumors, brain trauma, and neurogenic diseases (During 
& Ashenden, 1998).  
Thus, there is a critical need for therapeutic strategies that can 
intervene at the genetic level in CNS disorders. The long term goal of this 
project is to develop novel technology that will enable gene modulation in 
targeted neurons to restore function.  
 
1.3 Genetic Intervention in CNS disorders 
Gene manipulation offers a precise approach for elucidating gene 
function and is also a powerful tool in the discovery of therapeutic targets. 
For instance, in neurological disorders, where one or more mutations in a 
gene(s) are responsible for the disease manifestation, the mutated gene(s) 
can be silenced to offer relief from diseased-proteins (During & Ashenden, 
1998). Alternatively, therapeutic-genes can be expressed to compensate 
for diseased or ineffective genes. In non-monogenetic neurological 
disorders with complex etiology, the cellular pathways that contribute to 
disease manifestation can be silenced while therapeutic genes encoding 
neuro-protective and pro-survival factors can be employed to prevent cell 
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loss (During & Ashenden, 1998). A specific example where the above 
mentioned therapeutic strategies can be applied is in PD (Figure 1).  
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Figure 1. Strategies for gene intervention in Parkinson’s disease. Image 
adapted by permission from Elsevier Ltd: Molecular Medicine Today 
(During & Ashenden, 1998) , copyright (2006).  
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Parkinson’s disease is one of the most debilitating neurodegenerative 
disorders, which is primarily characterized by the loss of dopaminergic 
neurons that project from the substantia nigra pars compacta to the 
corpus striatum (Dauer & Przedborski, 2003). One of the current 
pharmacological approaches for the treatment of Parkinson’s relies on 
compensating for the loss of dopamine by administering levodopa (L-
dopa), a dopamine precursor that is converted to dopamine by action of 
aromatic amino acid decarboxylase (AADC) (During & Ashenden, 1998). 
However, the efficacy of L-dopa treatments decreases over time and fails 
to prevent the disease progression. In a gene therapy based approach, the 
aforementioned limitation can be overcome by manipulating genes 
involved in the diseased pathway to maintain a continuous and regulated 
production of dopamine. For instance, rate limiting enzymes in the 
biosynthesis of dopamine, such as tyrosine hydroxylase (TH) and AADC, 
can be over expressed within striatal cells (During & Leone, 1997). In 
addition, the loss of neurons can be prevented by augmenting the 
expression of neurotrophic factors. Further advancements in the 
understanding of the etiology of Parkinson’s disease will help identify 
novel therapeutic genetic targets.  
The primary requirement for the implementation of gene therapy 
for treatment of neurological disorders is the identification of therapeutic 
genetic targets and the identification of target regions in the CNS for gene 
manipulation. The goal of this project is to develop a scalable technology 
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that will enable rapid discovery of therapeutic genetic targets for CNS 
disorders using a gene manipulation technique in a high-throughput 
fashion. The current strategies employed for gene manipulation are 
discussed in the following sub-section.  
 
1.3.1 Gene manipulation in CNS 
Two strategies currently employed for gene manipulation include 
gene expression and gene silencing. In gene expression, the gene of 
interest is packaged in a plasmid vector and delivered to desired cells to 
induce expression of the gene. On the contrary, gene silencing involves 
inhibition of a target gene expression. RNA interference (RNAi) is one of 
the most powerful approaches for suppressing genetic activity of targeted 
genes. RNAi technique involves the use of synthetically designed 20-25 
base pair long nucleotide sequences, known as small interfering RNA 
(siRNA), to suppress the translational activity of mRNA with 
complementary strand. Once introduced inside the cell, siRNA sequences 
bind to complementary sequences on target mRNA strand and initiate 
mRNA cleavage (H. Xia, Mao, Paulson, & Davidson, 2002), as seen in 
Figure 2.  
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Figure 2. Mechanism of RNAi based gene silencing. Image adapted by 
permission from Macmillan Publishers Ltd: Nature Chemical Biology 
(Bumcrot, Manoharan, Koteliansky, & Sah, 2006) , copyright (2006).  
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The technique of siRNA based gene silencing offers very high target 
specificity and potent target inhibition. Several recent studies have 
demonstrated the applicability of siRNA as a therapeutic tool by silencing 
genes that contribute to disease manifestation (Boudreau & Davidson, 
2010). For instance, Xia et al. have demonstrated that RNAi targeting of 
mutant ataxin-1 in a mouse model of spinocerebellar ataxia type-1 
improved disease phenotype (H. Xia, Mao, Eliason, Harper, Martins, Orr, 
Paulson, Yang, Kotin, & Davidson, 2004). In another proof of concept 
study, Singer et al. demonstrated a decrease in neurodegenerative and 
behavioral deficits in a transgenic mouse model of Alzheimer’s by 
targeting BACE-1 (Singer et al., 2005). RNAi based gene silencing can also 
be used to modulate electrical activity of specific pathways in CNS. For 
instance, Pan et al. showed that silencing of SNAP-29, a synaptic receptor 
associated protein, led to an increase in synaptic strength (Pan et al., 
2005). There are many neuronal pathways, excitatory and inhibitory, 
involved in neurological diseases. By silencing specific genes in a selected 
group of neurons, functioning of the entire diseased pathway can be 
modulated.  
A key requirement for gene therapy is precise spatial control over 
delivery of genetic constructs. This is particularly important in CNS 
because of its complexity in both structure and function. In CNS, siRNA 
delivered to non-targeted neurons can risk provoking unwanted responses 
(Jackson & Linsley, 2010; Mahato, Cheng, & Guntaka, 2005). In addition, 
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spatial control over delivery is highly desirable in high-throughput 
genomic studies (Pepperkok & Ellenberg, 2006; Wheeler, Carpenter, & 
Sabatini, 2005).  
 
1.4 Current approaches for delivery of genetic constructs to neurons 
A major limitation in successful realization of gene manipulation in 
CNS is efficient, non-toxic and spatially restricted delivery of genetic 
payload and other molecules, such as drugs and proteins, to cells. 
Numerous strategies have been developed over the years to enable delivery 
of genetic material to cells. The current delivery strategies can be grouped 
in viral and non-viral delivery technologies.  
 
1.4.1 Viral delivery 
Viral vectors are recombinant viruses , such as retroviruses, 
lentiviruses, adenovirus, and herpes simplex virus (HSV), packaged with 
genes to be delivered without the toxic genetic components of the viruses , 
as shown in Figure 3 (Walther & Stein, 2000).  
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Figure 3. Viral vector mediated transduction. Image adapted by 
permission from Macmillan Publishers Ltd: Nature Medicine (Naldini, 
2001), copyright (2001). 
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Virus vectors offer one of the most efficient methods for gene transduction 
particularly in hard-to-transfect cell lines such as primary neurons 
(Washbourne & McAllister, 2002). In addition, the viral vectors can be 
designed to target specific cell-types for transduction. Typically, the viral 
vectors can either be delivered locally by injecting them into the target site 
or globally by injecting them in ventricular system or by systemic delivery 
(Davidson & Breakefield, 2003). Local delivery of viral vectors is beneficial 
in applications that require spatially controlled transfection. The use of 
viral vectors has been demonstrated for gene expression as well as RNAi 
based gene silencing both in vivo and in vitro (H. Xia, Mao, Paulson, & 
Davidson, 2002).  For example, in a study Xia et al. (2004) demonstrated 
the therapeutic potential of viral vector mediated RNAi in a transgenic 
mouse model (SCA1-82Q) of spinocerebellar ataxia (H. Xia, Mao, Eliason, 
Harper, Martins, Orr, Paulson, Yang, Kotin, & Davidson, 2004). In this 
study, AAV1 viruses packed with shRNAs against human ataxia-1 were 
directly injected in the cerebellum of the SCA1-82Q mouse. The SCA1-82Q 
mice treated with RNAi demonstrated significant improvement in motor 
coordination and neuropathology highlighting the potential of viral 
delivery of genetic constructs. However, major disadvantages with viral 
vectors include cytotoxicity, immunogenicity, and insertional mutagenesis 
(During & Ashenden, 1998). In addition, the viral delivery techniques are 
complex, time consuming, expensive and always carry a risk of infection.  
In contrast to viral techniques for transfection, non-viral techniques have a 
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lower risk of immune response and a higher chance of approval by the 
FDA for use in clinical trials.  
 
1.4.2 Non-viral delivery  
Non-viral delivery techniques offer cost-effective and less toxic 
alternatives to viral methods. Non-viral methods for transfection can be 
categorized into two groups, chemical and physical methods. Chemical 
methods of transfection include cationic lipids, cationic polymers and 
nanoparticles. Unlike the viral transfection, chemical transfection is not 
limited by the size of the genetic payload. Physical methods involve 
creation of transient pores in cell membrane using physical forces. The 
major current physical methods are magnetofection, sonoporation, and 
electroporation.  
 
1.4.2.1 Cationic lipids and polymers 
The cationic lipids and polymers facilitate DNA/siRNA uptake by 
encapsulating them in unique condensed complexes by electrostatic 
interactions (Al-Dosari & Gao, 2009). Owing to the high positive charge 
density, the DNA-lipid (lipoplexes) or DNA-polymer (polyplexes) 
complexes electrostatically interact with the negatively charged molecules 
on the cell membrane and subsequently internalize them through 
endosomes (Figure 4). The encapsulation of the DNA/siRNA also protects 
the nucleic acids from degradation agents such as nucleases.  
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Figure 4. Cationic lipid based transfection: Lipoplex formation and 
endosomal escape of DNA.  Image adapted from http://www.nano-
lifescience.com/research/gene-delivery.html  
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The cationic lipids typically consist of a positively charged hydrophilic 
head connected to a carbon based hydrophobic tail via a linker (Wasungu 
& Hoekstra, 2006). Over the years, hundreds of cationic lipids have been 
developed and validated, all of which share the common structure of 
hydrophilic head and hydrophobic tail (Al-Dosari & Gao, 2009). In the 
lipoplex structure, the DNA/siRNA molecules are surrounded by the 
cationic lipids forming compact structures with a net positive charge. Once 
inside the cell, the lipoplex escape from the endosomes and DNA/siRNA 
molecules disassociate from the cationic lipids in the cytoplasm (Al-Dosari 
& Gao, 2009). A major disadvantage of the lipoplex-mediated delivery of 
nucleic material is the low transfection efficiency in primary cell lines (Al-
Dosari & Gao, 2009).  
Cationic polymer mediated-transfection involves the use of 
branched or linear polymers such as polyethylenimine (PEI) to form 
nanosized complexes with DNA/siRNA (Matsumoto, Itaka, Yamasoba, & 
Kataoka, 2009; Pérez-Martínez, Guerra, Posadas, & Ceña, 2011). PEI is the 
most extensively used polymer as a transfection agent. The presence of 
amine groups in the PEI backbone provides it with a high cationic charge 
density. Unlike the cationic lipids, the polyplexes dissociate from the DNA 
after entry into the nucleus (Matsumoto, Itaka, Yamasoba, & Kataoka, 
2009). The dissociation of the DNA from the polymer in the nucleus is the 
most critical step; it is a bottleneck for transfection efficiency in polymer-
based transfection as incomplete dissociation can interfere with 
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transcription activity (Pérez-Martínez, Guerra, Posadas, & Ceña, 2011). 
However, a major advantage of PEI over the cationic lipids, apart from the 
relatively small size of polyplexes, is the ability of PEI to retain a 
significant buffering capacity thereby protecting the DNA/siRNA from the 
acidic environment of the lysosomes (Al-Dosari & Gao, 2009). 
Major drawbacks of cationic lipid and cationic polymer based-
transfection include low transfection efficiency in post-mitotic cell lines 
and toxicity at high concentrations. In addition, both of these techniques 
are bulk in nature and provide limited or no spatial-temporal control over 
transfection region.  
 
1.4.2.2 Inorganic nanoparticles 
Nanoparticle-mediated gene transfection is amongst the latest and 
most promising technique for high efficiency transfection in all cell types. 
A typical strategy for use of inorganic nanoparticles (gold, silicon, carbon 
nanotubes and silver) involves modification of the nanoparticle surface 
with positive charge to facilitate electrostatic binding with DNA (Z. P. Xu, 
Zeng, Lu, & Yu, 2006). The major advantage with the use of nanoparticles 
is the small size of the particles that can bypass most cellular and 
physiological barriers and result in gene silencing or expression (Z. P. Xu, 
Zeng, Lu, & Yu, 2006). The nanoparticles can also be modified to be 
transported through specific receptors enabling target specificity (Gupta & 
Curtis, 2004). Nanoparticles-mediated gene delivery has demonstrated 
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high transfection efficiency both in vivo and in vitro as well as low cell 
cytotoxicity in neurons. However, a major limitation of the use of 
nanoparticles in neuronal studies is the lack of spatial control over the 
transfection region.  
 
1.4.2.3 Magnetofection 
Magnetofection involves delivery of genetic material associated 
with magnetic particles to cells in the presence of magnetic fields (Buerli et 
al., 2007). In this approach, plasmid vectors associated with magnetic 
particles are incubated with cells in the presence of a magnetic field which 
drives the magnetic vectors towards the cells resulting in transfection 
(Figure 5). The use of magnetofection has been demonstrated both in vivo 
and in vitro (Scherer et al., 2002). Magnetofection offers an easy to use 
method for transfection (Buerli et al., 2007). However, transfection 
efficiency for neurons is low and spatial control over deliver with 
magnetofection remains to be demonstrated and would require complex 
experimental setup (Buerli et al., 2007).  
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Figure 5. Magnetofection: DNA-lipid complexes associated with magnetic 
vectors are driven towards the cells surface under the influence of 
magnetic fields. Image adapted by permission from Elsevier Ltd: Journal 
of Magentism and Magnetic Materials (Schillinger et al., 2005), copyright 
(2005).  
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1.4.2.4 Sonoporation  
Sonoporation involves the application of ultrasound waves to target 
cells/tissue to create transient defects in the cell membrane by acoustic 
cavitation, and thus allow the entry of exogenous molecules into the cell 
(ter Haar, 2007). In sonoporation, ultrasound irradiation is applied to 
cells in the presence of air-filled microbubbles, which are used as gene 
delivery vehicles. In the presence of an acoustic field, the microbubbles 
undergo forceful oscillations and breakup, resulting in high-velocity shock 
waves that disrupt and cause pore formation in the nearby membrane 
(Endoh et al., 2002). Several studies have been successful in 
demonstrating ultrasound enhanced gene delivery in vitro and in vivo (ter 
Haar, 2007). The main advantage of sonoporation is non-toxicity and 
noninvasiveness. In addition, ultrasound can be focused on a desired 
region to achieve targeted transfection (Tsunoda et al., 2005). However, a 
major limitation of sonoporation has been relatively low transfection 
efficiency, especially in primary neurons.  
 
1.4.2.5 Electroporation 
Electroporation-assisted gene delivery was first demonstrated by 
Neumann et al. in mouse lyoma cells. Since then, electroporation has been 
widely adopted as a technique for gene delivery both in vitro and in vivo. 
In electroporation, gene delivery is accomplished by exposing cells to brief 
pulses of high intensity electric field which leads to a temporary change in 
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the permeability of the membrane. It is the transient change in the 
permeability of the membrane that allows entry of exogenous molecules 
into the cells (Figure 6).  
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Figure 6. Electroporation: Application of a high intensity electric field 
leads to formation of pores in the membrane thereby increasing molecular 
uptake. Image adapted from http://www.btxonline.com/  
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Unlike chemical methods for transfection, electroporation allows 
delivery of naked siRNA and plasmid DNA molecules directly inside the 
cell, thereby averting the critical limiting step of liposomal escape 
associated with chemical transfection. In addition, the use of 
electroporation can be extended for delivery of various molecules 
including drugs, dyes, plasmid DNA, siRNA, and shRNA. Moreover, 
electroporation has shown to offer transfection efficiencies comparable to 
that of viral transfection without the risk of provoking an immune 
response. Traditionally, electroporation is performed by applying an 
electric field to a suspension of cells in electroporation buffer containing 
probe molecules placed between two parallel plate metal electrodes. The 
traditional system is limited to cells in suspension; however, recent studies 
have demonstrated the implementation of electroporation at a microscale 
level, enabling delivery of macromolecules to cells in vitro and in vivo with 
precise spatial and temporal control over the region of transfection.  
 
1.5 Theory of electroporation  
Electroporation is a biophysical phenomenon in which the 
permeability of the cell/bilayer membrane increases transiently in the 
presence of a high intensity electric field, allowing the transport of ions, 
polar and non-polar molecules across the membrane (Neumann, Schaefer-
Ridder, Wang, & Hofschneider, 1982; Neumann, 1992). The key steps 
involved in electroporation are the following (Weaver, 2000):  
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1. Exposure of cell(s)/tissue(s) to high intensity electric field on a 
microsecond to millisecond time scale. 
2. Electric field-induced charging of the cell membrane. 
3. Rapid and localized rearrangement of molecular structures, such as 
proteins and lipids, within the membrane. 
4. Localized formation of aqueous pores which span through the 
thickness of the membrane. 
5. A several fold increase in ionic and molecular transport across the 
membrane via the aqueous pores.  
6. Membrane recovery and pore resealing upon the removal of an 
externally applied electric field. 
The cell membrane is a semi-permeable lipid bilayer that permits 
transport of small water and lipid soluble low-molecular-weight molecules 
freely while remaining impermeable to macromolecules, such as nucleic 
acids. The cell membrane can be considered as a dielectric separating the 
conductive intracellular and extracellular solutions. In the presence of an 
externally applied electric field, the membrane acts as a dielectric in a 
capacitor and becomes charged. The transmembrane potential        
induced across the membrane of a cell by an externally applied electric 
field Eext can be described by the equation: 
                      
 
 
                                                                                     
Where   is the angle between the membrane site and the direction of the 
applied field, r represents the radius of the cell, t is the time after the 
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electric pulse onset,   is the membrane charging time constant and   
represents the form factor of the cell (Bernhardt & Pauly, 1973; J. M. 
Escoffre et al., 2009; Neumann, 1992). The form factor of the cell 
describes the impact of the cell on the electric field distribution. It is 
dependent on the conductivities of the external solution   , cell interior    
and the cell membrane   . For   <<   ,    the form factor   for spherical 
cells is given by: 
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Where d is the thickness of the membrane (Neumann, 1992). The 
transmembrane potential at any site on the cell membrane is the sum of 
the induced potential due to the applied electric field at that site and 
resting membrane potential       (Mehrle, Hampp, & Zimmermann, 1989; 
Neumann, 1992) and can be described by the equation:  
                
 
 
                                                                                         
Electroporation of a cell is achieved when the superimposed 
transmembrane potential of the cell exceeds a certain threshold      
(equation 3). Experimental studies have demonstrated the value of     to 
be in the range of 0.2 – 0.3 V (Gabriel & Teissie, 1997; Teissié & Rols, 
1993). It is believed that at the critical value of the transmembrane 
potential, a dielectric breakdown of the membrane occurs, which results in 
the formation of aqueous pores (Hibino, Shigemori, Itoh, Nagayama, & 
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Kinosita, 1991; Weaver, 2003; Zimmermann, Pilwat, & Riemann, 1974). 
The critical electric field necessary of electroporation derived from 
equation 3 is given by:  
   
         
           
 
  
                                                                                                      
For a spherically shaped cell, when an electric field of amplitude equal to 
Ec is applied, electroporation occurs only for   values close to 0 or π 
(equation 4). In this situation, only the section of the membrane facing the 
electrodes is electroporated as shown in Figure 7.  
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Figure 7. Electroporation observed at poles facing the electrodes. Top: 
Electroporation leads to the formation of aqueous pores. Bottom right: 
Entry of a dye into the cell after electroporation is observed only at the 
sides facing the electrodes. Image adapted by permission from John Wiley 
and Sons: Acta Physiologica (Gehl, 2003), copyright (2003).  
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The strength of the electric field controls the area of the cell membrane 
that undergoes electroporation (Schwister & Deuticke, 1985). Another 
observation that can be made from equation 1.4 is that the strength of the 
critical electric field is inversely related to the radius of the cells. Thus for 
electroporation, larger cells (i.e. mammalian cells) require an electric field 
with lower strength when compared to smaller cells (i.e. bacteria) (Teissié 
& Rols, 1993). The nature of permeabilization is dependent on the strength 
of the applied electric field. At electric field strengths equal to or slightly 
higher than Ec, the poration of the membrane is temporary and reversible. 
However, at field strengths much higher than Ec, the cell membrane is 
irreversibly damaged, ultimately leading to cell death. The underlying 
phenomenon that allows the cell membrane to reseal after electroporation 
is not very well understood (Weaver, 2003). 
Studies investigating the kinetics of pore formation have reported that 
the process of resealing happens over a range of minutes (M. P. Rols & 
Teissié, 1990). One of the methods to characterize the dynamics of pore 
resealing, apart from fluorescence microscopy (Neumann, 1992), is by 
measuring the transmembrane potential and current during and after 
electroporation (Abidor et al., 1979; Krassen, Pliquett, & Neumann, 2007; 
Ryttsén et al., 2000). The aqueous pores formed in the membrane due to 
an externally applied electric field behave as conductive channels and as a 
result lead to an increase in the conductance of the cell membrane. The 
change in the conductance of the membrane can be captured by measuring 
  28 
the current flow through the membrane. Ryttesen et al. used a patch clamp 
with NG108-15 cells to demonstrate that pore resealing is a two-step 
process (Ryttsén et al., 2000); wherein cells display a high conductance 
state within 100 msec after electric pulse application and typically recover 
from the high conductance state within 500 msec. Following recovery 
from the high-conductance state, the cell membranes remain in a low 
conductance state in the range of minutes to hours. The recovery time also 
depends on the strength of the applied electric pulse; longer recovery 
times are observed for higher strength of electric pulse.  
The manner of entry of probe molecules into the cell cytoplasm via 
electroporation largely depends on the size and charge of the molecules 
(Gehl, 2003). Small molecules (such as dyes and anticancer drugs) have 
been shown to enter cells by free and rapid diffusion regardless of charge 
during the life time of the pores (Gehl, 2003; Neumann, Tönsing, Kakorin, 
Budde, & Frey, 1998). However, entry of macromolecules such as plasmid 
DNA into the cytoplasm is a complex multistep process (Figure 8), which 
includes the following (J. M. Escoffre et al., 2009): 
1. Pore formation in the membrane. The process occurs on a 
microsecond time scale 
2. Electrophoretic migration of the plasmid DNA towards the 
membrane surface facing the cathode. The process occurs in a 
millisecond time scale.  
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3. DNA-membrane interaction and complex formation. The process 
occurs in a second time scale. 
4. Translocation of the DNA to the cytoplasm. It takes upto 30 mins 
for DNA translocation to the cytoplasm. 
5. DNA entry into the nucleus. It can take upto an hour after pulse 
application for DNA to enter the nucleus.  
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Figure 8. Mechanism of electroporation assisted plasmid entry into cell. 
Image adapted by permission from Springer: Molecular Biotechnology, (J. 
M. Escoffre et al., 2009), copyright (2009). 
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The exact mechanism involved in the DNA-membrane interaction, 
complex formation and subsequent translocation to cytoplasm is not fully 
understood (J. M. Escoffre et al., 2009). Recent evidence from studies 
suggests that an important role is played by the cytoskeleton (actin 
filaments) by actively participating in DNA uptake following electric pulse 
application (Rosazza, Escoffre, Zumbusch, & Rols, 2011; Teissie & ROLS, 
1994). The formation of DNA-membrane complexes undergoes a two stage 
process (Golzio, Teissié, & Rols, 2002). First, metastable DNA-membrane 
complexes are formed, from which plasmid DNA can leave the membrane 
and return to the extracellular medium under the influence of a reverse 
direction electric field. Second, within 1 second following pulse 
application, the metastable DNA-membrane complexes convert to highly 
stable complexes. Next, the plasmid DNA is translocated to the cytoplasm. 
Another key aspect of DNA delivery via electroporation is that plasmid 
DNA enters cells on the side facing the cathode (Golzio, Teissié, & Rols, 
2002). This phenomenon is primarily caused by the electrophoretic 
migration of DNA towards the side of the cell facing the cathode due to its 
negative charge. 
 
1.6 Microscale electroporation assisted gene manipulation 
In the conventional form of electroporation, a large volume 
biological sample (in the range of a few cubic centimeters) is typically 
placed in a cuvette between two parallel metallic plate conductors and a 
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high intensity electric field is applied to the sample to achieve 
electroporation. In contrast, microscale electroporation involves 
controlled application of electric field to a targeted region of the biological 
sample (in the order of microns) using microelectrodes to achieve 
electroporation. There are many advantages to microscale electroporation 
over the conventional form of electroporation, which include (W. G. Lee, 
Demirci, & Khademhosseini, 2009) (1) symmetric and uniform electric 
fields, (2) precise spatial control over the transfection area, up to single 
cells, (3) high transfection efficiency in hard-to-transfect cell lines, (4) 
rapid optimization of electroporation parameters, (5) in situ assessment of 
cellular response to electric field, (6) applicable for in vivo, in vitro and in 
utero setting (S. Li, 2004; Pacary et al., 2012).  
Microscale electroporation has proven capability to transfect 
spatially restricted neurons, up to single cells, with high transfection 
efficiency of up to 30% (using micropipette based approach). For instance, 
Haas et al. (2001) demonstrated single cell electroporation in a tadpole by 
positioning a micropipette close to the cell. A microelectrode placed inside 
the micropipette was used to generate and apply the electric field to a 
target neuron for electroporation. The technique developed by Hass et al. 
(2001) and similar approaches by others has shown high transfection 
efficiency in single neurons and localized transfection in the brain (Åberg 
et al., 2001; Akaneya, Jiang, & Tsumoto, 2005; Kitamura, Judkewitz, 
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Kano, Denk, & Häusser, 2007; Matsuda & Cepko, 2004; Nevian & 
Helmchen, 2007; Tanaka, Yanagawa, & Hirashima, 2009).  
In addition, microscale electroporation has been demonstrated in high-
throughput applications and offers many advantages over conventional 
high-throughput systems. For instance, current high-throughput systems 
for gene screening involve use of microwell plates (96 or 384 wells) and 
rely on chemical transfection, which is known to be inefficient in primary 
neuron transfection (Vanhecke & Janitz, 2005). The microwell based 
screening is a time consuming and expensive process (due to the large 
amount of reagent needed). For example, a pooled siRNA based genome 
wide screen would require 267 96-well plates (M. Jiang, Instrell, Saunders, 
Berven, & Howell, 2011). If three replicates were to be performed (total 
801 plates) at a well manipulation time of 1 min/well, it would require 13 
hours to process all the wells. On the contrary, microscale electroporation 
enables miniaturization of the high-throughput system, thereby increasing 
the speed and reducing the cost. For instance, Tilak et al. (2012) 
demonstrated a miniaturized electroporation ready microwell system. In 
this approach, microfabrication techniques were used to create a micro-
pattern of wells on a conductive substrate. The conductive substrate 
allowed parallel electroporation of cells in all the wells immediately after 
seeding. siRNAs were spotted individually in each of the wells prior to 
seeding. Similar approaches have been demonstrated by several other 
groups (Z. Li, Wei, Li, Du, & Liang, 2011); however, some major 
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limitations with these approaches have been 1) limited temporal control 
over transfection, due to siRNA spotting, which is a key requirement in 
studies involving primary neurons and 2) studies involving primary 
neuronal cultures can greatly benefit from technology that integrates the 
capability to record electrical activity of targeted neurons and the entire 
neuronal network in real time. It is hypothesized that a novel optically 
transparent microelectrode array (MEA) based biochip can be fabricated 
to spatially target and transfect a population of primary neuronal cells 
in vitro in a high throughput fashion using electroporation. In addition, 
the MEA can be used for simultaneous electrophysiological assessment of 
neurons. 
 
1.7 Preface to the following chapters 
Chapter 2 describes a detailed protocol and experimental setup for 
targeted transfection in adherent cells using a custom made or 
commercially available microelectrode array (MEA). The protocol 
describes strategies for rapid optimization of electroporation parameters 
for transfection with siRNA and GFP. The protocol was designed to make 
this technique accessible to most research labs with basic cell culture 
equipment.  
Chapter 3 presents the development of an optically transparent 
platform for spatially and temporally controlled transfection in adherent 
cells in a high-throughput fashion. In this chapter, targeted transfection 
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using the developed MEA based biochip is demonstrated in a secondary 
cell line (HeLa cells). Electroporation parameters were optimized for three 
different electrode sizes. Finite element method was used to simulate 
electric field intensities associated with the three electrode sizes. The 
electric field simulation predicted the regions of cell death on the three 
electrode sizes. Biomolecules such as functional siRNA and GFP were 
delivered to targeted cells and phenotypical changes were measured. The 
impact of microscale electroporation on cells was measured by monitoring 
dynamic changes in sub-cellular structures (Actin). Chapter 3 shows 
successful demonstration of the initial hypothesis in a secondary cell line.  
Chapter 4 reports for the first time, targeted transfection of genetic 
payloads of different sizes and molecular characteristics such as GFP 
plasmids and fluorescently tagged siRNA molecules (Alexa 488-siRNA) in 
a primary culture of hippocampal neurons using the MEA based biochip. 
In addition, the MEA was used to measure the electrical activity of 
neurons and assess the impact of the electroporation on neural activity. 
Finally, is reported for the first time delivery of GFP plasmids to neurons 
through electroporation of neuronal processes. Chapter 4 shows further 
validation of the initial hypothesis.  
Chapter 5 reports the use of nano-porous alumina membrane in 
tandem with MEA for achieving targeted nanochannel based 
electroporation in adherent cells.  In chapter 5, it is hypothesized that 
integration of MEA with nanochannels will provide a high-throughput 
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method for transfecting cells with similar efficiency and consistency 
offered by single cell nanochannel electroporation. Proof-of-concept of the 
integrated approach was demonstrated by electroporating HeLa cells 
cultured on alumina membrane with an MEA placed underneath the 
alumina membrane. Electric field intensity at the opening of the 
nanochannel integrated with MEA was performed to predict region of 
electroporation. Electrical characterization of the MEA nanoporous 
membrane assembly was performed to assess the suitability of the 
platform in measuring neural activity.  
Chapter 6 presents the conclusion of the results obtained in this 
dissertation work and identifies potential future work directions. Critical 
limitations are addressed and strategies for further development of the 
technology reported in this work are suggested.  
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CHAPTER 2 
HIGH EFFICIENCY, SITE-SPECIFIC TRANSFECTION OF ADHERENT 
CELLS WITH SIRNA USING MICROELECTRODE ARRAYS (MEA) 
 
2.1 Introduction 
The discovery of RNAi pathway in eukaryotes and the subsequent 
development of RNAi agents, such as siRNA and shRNA, have achieved a 
potent method for silencing specific genes (Brummelkamp, Bernards, & 
Agami, 2002; Caplen, Parrish, Imani, Fire, & Morgan, 2001; Elbashir et 
al., 2001; Fire et al., 1998; N. S. Lee et al., 2002; Miyagishi & Taira, 2002; 
Paul, Good, Winer, & Engelke, 2002; H. Xia, Mao, Paulson, & Davidson, 
2002) for functional genomics and therapeutics. A major challenge 
involved in RNAi based studies is the delivery of RNAi agents to targeted 
cells. Traditional non-viral delivery techniques, such as bulk 
electroporation and chemical transfection methods often lack the 
necessary spatial control over delivery and afford poor transfection 
efficiencies (Chu, Hayakawa, & Berg, 1987; Felgner et al., 1987; Jordan, 
Schallhorn, & Wurm, 1996; Raptis et al., 1995). Recent advances in 
chemical transfection methods, such as cationic lipids, cationic polymers 
and nanoparticles, have resulted in highly enhanced transfection 
efficiencies (Y. Gao, Liu, & Li, 2011). However, these techniques still fail to 
offer precise spatial control over delivery that can immensely benefit 
miniaturized high-throughput technologies, single cell studies and 
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investigation of cell-cell interactions (Wheeler, Carpenter, & Sabatini, 
2005).  
Recent technological advances in gene delivery techniques have 
enabled high-throughput transfection of adherent cells (H. Huang et al., 
2010; Jain & Muthuswamy, 2007a; Jain & Muthuswamy, 2007b; Jain & 
Muthuswamy, 2008; Jain, McBride, Head, & Saez, 2009; Jain, Papas, 
Jadhav, McBride, & Saez, 2012; Z. Li, Wei, Li, Du, & Liang, 2011; 
Yamauchi, Kato, & Iwata, 2004; Yamauchi, Kato, & Iwata, 2005; Ziauddin 
& Sabatini, 2001), a majority of which use microscale electroporation. 
Microscale electroporation offers precise spatio-temporal control over 
delivery (up to single cells) and has been shown to achieve high efficiencies 
(Akaneya, Jiang, & Tsumoto, 2005; K. Haas, Sin, Javaherian, Li, & Cline, 
2001; Jain & Muthuswamy, 2008; W. G. Lee, Demirci, & Khademhosseini, 
2009). Additionally, electroporation based approaches do not require a 
prolonged period of incubation (typically 4 hours) with siRNA and DNA 
complexes as necessary  in chemical based transfection methods and lead 
to direct entry of naked siRNA and DNA molecules into the cell cytoplasm. 
As a consequence, gene expression can be achieved as early as six hours 
after transfection (Boukany et al., 2011). The use of microelectrode arrays 
(MEA) for site-specific transfection in adherent mammalian cell cultures 
has been previously demonstrated (Jain & Muthuswamy, 2007a; Jain & 
Muthuswamy, 2007b; Jain & Muthuswamy, 2008).  In the MEA based 
approach, delivery of genetic payload is achieved via localized micro-scale 
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electroporation of cells. An application of electric pulse to selected 
electrodes generates local electric field that leads to electroporation of cells 
present in the region of the stimulated electrodes. The independent 
control of the micro-electrodes provides spatial and temporal control over 
transfection and also enables multiple transfection based experiments to 
be performed on the same culture increasing the experimental throughput 
and reducing culture-to-culture variability. 
Here, detailed protocol and experimental setup for targeted 
transfection of HeLa cells with a fluorescently tagged scrambled sequence 
siRNA using electroporation is described.  The same protocol can also be 
used for transfection of plasmid vectors. Additionally, the protocol 
described here can be easily extended to a variety of mammalian cell lines 
with minor modifications. Commercial availability of MEAs with both pre-
defined and custom electrode patterns make this technique accessible to 
most research labs with basic cell culture equipment.  
 
2.2 Protocol 
 
2.2.1 MEA preparation 
1) MEAs for use in electroporation experiments can either be fabricated 
using standard photolithography technique as described in the 
following chapter or purchased directly from vendors of MEA 
manufacturers such as Multi Channel Systems 
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(http:/www.multichannelsystems.com/) and Alpha MED Scientific, 
Inc. (http://www.MED64.com). The MEAs used in the experiments 
were fabricated in-house at the clean room facility in Arizona State 
University, which is administered by the Center for Solid State 
Electronics Research (CSSER).  The MEAs used for these 
experiments had 32 indium tin oxide electrodes in an 8 by 4 array 
with electrode diameter sizes from 50-200 µm within a 1 cm inner 
diameter glass well. The glass well was bonded on the MEA using 
polydimethylsiloxane (PDMS).   
2) Sterilize the MEA in an autoclave prior to cell seeding. Other methods 
of sterilization such as a soaking in 70% ethanol, UV treatment and 
hot water treatment as described elsewhere can also be used as long 
they do not compromise the integrity of the MEA.  
3) Transfer the autoclaved MEA to a laminar flow hood and place it in a 
standard sterile polystyrene Petri dish.  Prior to seeding cells on the 
MEA sterilize the laminar flow hood by turning on the UV light for 20 
minutes.  If the MEA is sensitive to UV light cover the Petri dish 
containing the MEA with sterile aluminum foil while the flow hood is 
under UV illumination. 
  
2.2.2 Seeding cells on the MEA 
1) Harvest cells from a running cell line of adherent mammalian cells 
using Trypsin/EDTA and raise them to a concentration of 100-200 
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cells/µl in 1 ml cell media for plating. In these experiments, NIH 3T3 
fibroblasts cell line, HeLa cell line and primary cortical and 
hippocampal neurons were successfully cultured on the MEA.  
2) Place a 20-30 µl drop of media with cells on the MEA. Transfer the 
Petri dish with the MEA to the incubator. It is important to ensure 
that the cell drop size is large enough to cover all the electrodes on 
the MEA.  
3) 2 hours after seeding the cells transfer the Petri dish with the MEA 
from the incubator to laminar flow hood and gently add 400-500 µl 
of pre warmed media (37°C) to the MEA well. Check under the 
microscope to ensure that cells are still attached and evenly spread on 
the MEA surface. Transfer the MEA back to the incubator. The 2 hour 
wait period before the addition of media ensures enough time for the 
cells to adhere with the MEA surface. Addition of cell media too soon 
after seeding the cells can wash away the cells. If cells do not adhere 
well on the MEA, its surface can be treated with cell attachment 
factors such as polylysine, fibronectin, and laminin to improve cell 
adhesion. In the HeLa cell experiments, the MEA surface was treated 
with fibronectin (10 µg/ml) for 1-2 hours.  
4) 8-12 hours after seeding the cells, perform 1-2 washes with PBS to 
remove any dead cells. Cell medium can replaced every 24-48 hours 
as needed. In a typical experiment, the cells are usually ready for 
transfection 24-48 hours after seeding. To maintain consistency in 
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electroporation efficiencies it is recommended to wait until the 
culture is at least 80% confluent before electroporation.  
 
2.2.3 Site-specific transfection of siRNA 
1) Prepare nucleic acid solution. For siRNA transfection, prepare a 1-2 
µM siRNA electroporation solution in ice cold electroporation buffer 
to attain a final volume of 200-400 µl. This protocol demonstrates 
the procedure for successful transfection of HeLa cells with Alexa 488 
conjugated scrambled sequence of siRNA. 
2) Transfer the MEA with cells from the incubator to sterile laminar 
flow hood. Remove the cell media from the MEA and perform a wash 
with PBS. Thereafter, add 200-400 µl of the ice cold 1µM siRNA 
electroporation solution to the well.  
3) Apply anodic square electric pulses to the targeted electrodes (Refer 
to step 4 for determining optimal parameters of the electric pulse. A 
Pragmatic Instruments 2414A waveform generator can be used to 
generate electric pulses and a dual-inline-package (DIP) 16 pin clip to 
make contact with the MEA bond pads. The waveform generator can 
be connected to the DIP clip via a demultiplexor printed circuit board 
to provide selectivity of individual electrodes. For the reference 
electrode, place a steel cathode in the cell media.  While lowering the 
steel reference electrode in the media it is extremely important to 
ensure that it does not make contact with the MEA surface. Upon 
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contact, it can cause damage to the cells and the MEA. It is 
recommended to lower the reference electrode to a position of 1 mm 
above the cells. A spacer with a height of 1 mm can be placed in the 
well to assist in placement of the reference electrode. An alternate 
approach to using an external reference electrode is to use 
neighboring electrodes as cathode-anode pairs.   
4) Immediately after applying the electric pulses to the targeted 
electrodes on the MEA, transfer the MEA back to the incubator.  After 
an incubation period of 5 min, gently replace 75% of the 
electroporation buffer with pre-warmed (37°C) cell media. Later, 
fluorescent imaging can be done to confirm the delivery of 
fluorescently tagged siRNA to the cells.  
 
2.2.4 Electroporation parameter optimization 
1) To determine the optimal electric pulse parameters for 
electroporation, design electroporation experiments for a range of 
values of pulse amplitude, pulse duration, and number of pulses. In 
experiments with HeLa cells, it was observed that a single voltage 
pulse of amplitude from 3 V to 9 V, and duration from 1 msec to 10 
msec for an electrode size of 100 µm led to successful electroporation 
with minimal cell death. It is recommended that one parameter be 
varied at a time and others are kept constant. To quantitate the 
electroporation efficiency for each of the pulse parameters, use 
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propidium iodide (PI), a cell impermeant dye that stains nucleic 
material, and live assay based methodology, as described in steps 4.2-
4.5.  
2) Establish a cell culture on the MEA following the directions outlined 
in steps 1 and 2.  
3) Prior to electroporation prepare a 300-500 µl of 30 µg/ml PI solution 
in ice cold electroporation buffer and 400 µl of 4 µM calcien AM 
solution in PBS.     
4) Transfer the MEA from the incubator to the laminar flow hood. 
Remove the cell media from the MEA and perform a wash with PBS. 
Thereafter, add 300-500 µl of the ice cold electroporation buffer with 
PI.  
5) Apply electric pulses with desired pulse amplitude and duration to 
the targeted electrodes (The equipment used for generating and 
applying the electric pulse to the MEA is described in step 3.3). For 
the reference electrode either lower a steel electrode into the 
electroporation buffer in the MEA well or use the neighboring 
electrode as reference.  By selectively applying pulses of varying 
amplitudes or durations to different electrodes multiple experiments 
can be performed on the same device. For example, on a 32 electrode 
MEA, 8 experiments can be performed by splitting the 32 electrodes 
in 8 groups, each consisting of 4 electrodes. Each of the 8 groups can 
then be stimulated by a single rectangular voltage pulse of duration 5 
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msec with amplitudes varying in 3 V-6 V range in 0.5 V increments 
and one group can be used as a control.  
6) Immediately after applying the voltage pulses transfer the MEA to the 
incubator for 5 min. Afterwards, gently remove 75% of the 
electroporation buffer from the MEA well and replace it with warm 
cell media. Transfer the MEA back to the incubator. 
7) After an incubation period of 2-4 hours replace the cell media in the 
MEA well with 300-500 µl of 4 µM Calcein AM solution in PBS. 
Transfer the MEA back to incubator for another 30 min.  
8) Following the incubation of the cells with Calcein AM replace the 
Calcein AM solution in the MEA well with PBS after two washes with 
PBS. Obtain fluorescent images of cells using with an optical 
microscope with filters for PI (Excitation/Emission - 535 nm/617 
nm) and Calcein AM (Excitation/Emission – 490 nm/520 nm).  The 
uptake of PI, due to electroporation, causes cells to fluoresce red and 
the Calcein AM causes cells that are alive to fluoresce green.  Three 
possible scenarios that can be observed are 1) cell electroporated and 
alive (will fluoresce both red and green) 2) Cells alive but not 
electroporated (will fluoresce just green) 3) Cells dead due to 
electroporation (will fluoresce just red). The cell viability was 
calculated as a percent of the total number of cells alive on the 
electrode and the electroporation efficiency was calculated as percent 
of the total number of cells loaded with PI/siRNA.  
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2.3 Results  
Figure 9 shows the site-specific loading of HeLA cells with PI. It can 
be observed that only cells on the electrode demonstrate an uptake of PI 
(Figure 9(a)). A live assay performed post electroporation was used to 
assess the viability of cells (Figure 9(a)). The electroporation efficiency and 
cell viability for the example shown in Figure 9 are 81.8 % and 96.1 % 
respectively. High cell viability and electroporation efficiency can be 
achieved by optimizing the electroporation pulse parameters.  
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Figure 9. Site-specific delivery of PI in HeLa cells on a 200 µm electrode 
(6 V, 5 msec). (a) Calcein based live assay performed 2 hours post 
electroporation. Alive cells are indicated by green fluorescence. (b) Red 
fluorescence demonstrates the uptake of PI by cells on the electrode. (c) A 
superimposed image of (a) and (b). The white arrows indicates cells that 
are electroporated and alive. The black arrows indicate cells that are dead. 
The white circle in (a), (b) and (c) indicates the outline of the electrode. 
Scale bar is 50 µm. 
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2.4 Discussion and Conclusion 
In this work, the use of MEA for site-specific transfection of HeLa 
cells with scrambled sequence of siRNA was demonstrated.  One of the 
advantages of this technology is its applicability to different cell lines 
including primary cell lines.  The use of this technology for site-specific 
transfection of primary hippocampal neuronal culture from E18 day old 
rat and NIH-3T3 cells with scrambled siRNA sequences and GFP plasmid 
has been previously demonstrated (Jain & Muthuswamy, 2007a; Jain & 
Muthuswamy, 2008). Successful delivery of functional siRNA against an 
endogenous target was also demonstrated in HeLa cells (please refer to 
Chapter 2). A typical commercially available MEA is compatible with 
optical imaging (upright microscope), enabling quantitative assessment of 
functional impact of gene silencing, using fluorescent immunostaining 
techniques. Additionally, the microelectrodes in MEA can be used to 
monitor electrical activity of cells, such as primary neurons, in response to 
genetic perturbation. Currently a major limitation with the MEA based 
system is the large amount of siRNA needed for transfection (400 µl of 
1µM siRNA), which is high compared to conventional chemical 
transfection based approaches and thus limits the cost effectiveness of the 
system. This can potentially be overcome by incorporating microfluidics 
with the MEA based system to decrease the total volume of siRNA 
electroporation solution to less than a few microliters. Further 
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development of this technology offers a novel high-throughput, efficient 
and low cost method for gene manipulation studies.   
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CHAPTER 3 
 
A NOVEL OPTICALLY TRANSPARENT BIOCHIP FOR SITE-SPECIFIC 
TRANSFECTION OF BIOMOLECULES IN ADHERENT CELLS 
 
3.1 Introduction 
Recent advances in genomics and the advent of genome sequencing 
have created a need for technologies that can systematically and efficiently 
determine gene function. RNA interference (RNAi) offers one of the most 
powerful and practical approaches for decoding gene function in a high-
throughput fashion (Mohr, Bakal, & Perrimon, 2010). In RNAi, 
synthetically designed silencer RNA (siRNA) molecules, with a sequence 
that is complementary and unique to target mRNA, is commonly used to 
silence the activity of a target gene by preventing the translation process 
(Elbashir et al., 2001). The most significant obstacle between RNAi 
technology and its implementation in high-throughput studies is efficient, 
non-toxic and spatially targeted delivery of siRNA molecules to cells in 
culture (Whitehead, Langer, & Anderson, 2009). Spatial control over 
delivery of siRNA molecules to cells in a culture is highly desirable in high-
throughput gene screening and cell-cell interaction studies (Wheeler, 
Carpenter, & Sabatini, 2005).  In addition, spatial control over delivery of 
genetic material enables multiple experiments to be performed on a cell 
culture thereby reducing culture-to-culture variability. Current approaches 
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for siRNA transfection, such as physical methods (electroporation 
(Prasanna & Panda, 1997), magnetofection (Scherer et al., 2002), 
sonoporation(Miller, Pislaru, & Greenleaf, 2002) ) and chemical methods 
(cationic lipids (Lonez, Vandenbranden, & Ruysschaert, 2008), cationic 
polymers (Park, Jeong, & Kim, 2006) and nanoparticles (Ghosh, Han, De, 
Kim, & Rotello, 2008) ) fail to deliver the desired spatial control over 
delivery.  Advances in nanoparticle based transfection have allowed 
receptor mediated targeted delivery of siRNA to cells (S. D. Li & Huang, 
2006); nonetheless, lack spatial control over delivery.  
Microscale electroporation has demonstrated precise spatial and temporal 
control over transfection both in vivo and in vitro (W. G. Lee, Demirci, & 
Khademhosseini, 2009; Olofsson et al., 2003). In microscale 
electroporation, strong localized electric fields are generated to selectively 
transfect the region of interest. Micropipettes (K. Haas, Sin, Javaherian, 
Li, & Cline, 2001; Tanaka, Yanagawa, & Hirashima, 2009), electrolyte 
filled capillaries (Nolkrantz et al., 2001), AFM tips (Nawarathna, Unal, & 
Wickramasinghe, 2008) and nanochannels (Boukany et al., 2011) have 
been established for their utility in electroporation. These methods 
provide a very high level of spatial control allowing selective 
electroporation of single cells and subcellular structures; however, they are 
low throughput in nature due to the skilled and precise manipulation 
required for positioning of the electroporation probes either in the vicinity 
or in contact with the cell membrane. Recently, standard MEMS based 
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fabrication techniques have been increasingly employed to develop 
platforms that allow microscale electroporation (W. C. Chang & Sretavan, 
2009; Hai & Spira, 2012; K. S. Huang, Lin, Su, & Fang, 2006; Y. Huang & 
Rubinsky, 2001; Inoue, Fujimoto, Ogino, & Iwata, 2008; Ishibashi, Takoh, 
Kaji, Abe, & Nishizawa, 2007; Jain & Muthuswamy, 2007a; Jain, Papas, 
Jadhav, McBride, & Saez, 2012; Y. C. Lin, Jen, Huang, Wu, & Lin, 2001; Y. 
C. Lin, Li, Fan, & Wu, 2003; Olbrich, Rebollar, Heitz, Frischauf, & 
Romanin, 2008; Valero et al., 2008; Valley et al., 2009; C. Xie, Lin, 
Hanson, Cui, & Cui, 2012; Y. Xu, Yao, Wang, Xing, & Cheng, 2011; Zhan, 
Wang, Bao, & Lu, 2009). Microfabrication of lab-on-chip style device 
provides the unique ability to integrate tools for cell manipulation, 
transformation and phenotype detection in a single platform. For instance, 
Xu et. al demonstrated a device that allowed microscale electroporation of 
adherent cells cultured within microwells (Y. Xu, Yao, Wang, Xing, & 
Cheng, 2011). The electroporation in each well was carried out by applying 
an electric pulse to a microelectrode present at the bottom of each well 
directly beneath the adherent cells. In addition to electroporation, the 
same microelectrodes were also used for patterning cells in microwells at 
seeding using dielectrophoresis. Several similar microwell based 
approaches have been developed for high-throughput studies (H. Huang et 
al., 2010; Jain, Papas, Jadhav, McBride, & Saez, 2012; Y. Xu, Yao, Wang, 
Xing, & Cheng, 2011); however, a major limitation with such approaches is 
their inapplicability in cell-cell interaction studies.  
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The use of a microelectrode array (MEA) for delivery of nucleic acids to 
pre-determined locations in an adherent cell culture using microscale 
electroporation has been previously demonstrated (Jain & Muthuswamy, 
2007a; Jain & Muthuswamy, 2007b; Jain & Muthuswamy, 2008). In the 
above mentioned MEA based approach, application of small electric pulses 
to the independently controllable microelectrodes allowed targeted 
electroporation of cells adhered directly on top of the patterned 
microelectrodes. The MEA based approach offers a novel scalable platform 
for delivery of nucleic material with precise spatial and temporal control to 
cells in culture with integrated capability to monitor electrical activity of 
cells such as primary neurons. A major limitation of the MEA based device 
was its optical opaqueness, due to silicon substrate, that impeded imaging 
based assays. Compatibility with standard imaging equipment is critical 
for most biological experiments. In this study, the fabrication of indium tin 
oxide (ITO) based fully optically transparent MEA for site-specific 
transfection is reported. More specifically, the use of patterned ITO MEA 
for endogenous gene silencing in targeted cells using siRNA was 
demonstrated for the first time. Additionally, microelectrodes of three 
different sizes were patterned to investigate the impact of electrode size on 
electroporation efficiency. Furthermore, the applicability of the biochip for 
assessing subcellular phenotypes was showns by investigating the impact 
of microscale electroporation on actin, its disruption and reorganization 
post electroporation. 
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3.2 Materials and Methods 
 
3.2.1 MEA fabrication 
The MEA was fabricated using a standard photolithography 
technique in a clean room facility. A schematic for the photolithography 
steps is shown in Figure 10(a).  First, the ITO wafers were cleaned with 
isopropanol and then coated with 50nm thick layer of chromium using a 
thermal evaporator. After chromium deposition, the first photolithography 
step was carried out using a positive photoresist, AZ 3310, to pattern bond 
pads and alignment marks. The bond pads and alignment marks were 
patterned in chromium. Since ITO is optically transparent, patterning the 
bond pads and alignment marks in chromium ensured that they remained 
visible throughout the fabrication process; visible alignment marks were 
necessary for subsequent photolithography steps and visible bond pads 
were assistive in making an electrical interface to access the electrodes.  
Prior to the second photolithography step, ITO wafers were heated at 
175°C for 45 min to remove moisture from the surface.  The moisture 
removal from the ITO surface facilitated better photoresist adherence. A 
second photolithography step was then carried out to pattern the 
electrodes, bond pads and traces in ITO. ITO was etched using ITO 
etchant, TE-100, purchased from Transene, Inc. (MA, USA). Following the 
second photolithography step, a 1.0 µm thick parylene layer was deposited 
using chemical vapor deposition as an insulation layer on the ITO wafer. 
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Figure 10. (a) Fabrication steps for the ITO based MEA. (b) An image of 
the biochip and schematic of two different MEA patterns and electrodes 
sizes. (c) Comparison of brightfield imaging of cells on ITO based MEA 
(left) and silicon based MEA (right) (d) Image of cells stained for actin  
filaments (green) and nucleus (blue) on a 100 µm ITO electrode.  
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A final photolithography step was then carried out to expose the bond 
pads and electrodes. Parylene etching was done using oxygen plasma. A 
glass well with 1.5 cm diameter and 1 cm height was bonded on the MEA 
using polydimethylsiloxane (PDMS) as an adhesive.  PDMS was cured in a 
conventional dry oven at a temperature of 80°C for 45mins. Using the 
above described approach, two different MEA patterns were fabricated, 
each with 32 total electrodes, as shown in Figure 10(b). One of the patterns 
had electrodes of three different sizes (50 µm, 100 µm and 200 µm 
diameters) while the other had all electrodes of the same size (100 µm 
diameter).  
 
3.2.2 Cell culture 
HeLa cells were grown in DMEM supplemented with 1% FBS, 1% 
penicillin-penstrep and 1% glutamate. The HeLa cell culture was 
maintained in a humidified incubator at 37°C and 5% CO2.  The MEA was 
sterilized by autoclaving at 122°C for 30 mins. Post sterilization, the MEA 
surface was treated with fibronectin (10 µg/ml) for two hours at room 
temperature to improve adhesion, followed with DI water washes. 
Thereafter, cells were harvested using Trypsin/EDTA and raised to a 
concentration of 200 cells/µL in fresh media. Subsequently, 30-35 µl of 
cells were pipetted on the MEA surface and the device was transferred to 
an incubator. Following a 2 hr incubation period that was allowed for the 
cells to adhere on the MEA surface, 500-600µl of pre-warmed and CO2 
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equilibrated cell media was added to the MEA well. The MEA was then 
quickly transferred back to the incubator.  
 
3.2.3 Experimental setup and imaging 
A 16 pin dual-inline-package (DIP) clip was used to electrically 
interface with the MEA bond pads. Electric pulses for electroporation were 
generated using a waveform function generator (Pragmatic 2414A, 
Pragmatic Instruments) and was connected to the DIP clip via an 8 
channel custom made demultiplexor circuit board. A flat steel electrode 
covered in sterilized aluminum foil was used as a ground in the 
electroporation experiments and was positioned 1 mm directly above the 
cells using a metallic spacer. The cells were imaged using either an 
inverted or upright fluorescent microscope. Fluorescent images were 
captured on an inverted microscope and were processed in ImageJ.  
 
3.2.4 Experimental protocol 
The experimental protocol is described in detail in Chapter 2(Patel 
& Muthuswamy, 2012). Electroporation experiments were generally 
carried out when the cells reached 80-100% confluency. Prior to 
electroporation, a solution of probe molecule (propidium iodide, siRNA or 
GFP) in electroporation buffer was prepared (cat. no. #165-2677, Biorad 
laboratories, CA, US) and maintained at 4°C.  Thereafter, cell media was 
replaced with electroporation buffer containing biomolecules and single 
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electric pulses, with predetermined pulse amplitudes and pulse widths, 
were applied to targeted electrodes. Immediately afterwards, the MEA was 
transferred to the incubator. Following a 10 min incubation period, 70-
80% of the electroporation buffer in the MEA well was replaced with pre-
warmed and CO2 equilibrated cell media and the MEA was placed back in 
the incubator.  
 
3.2.5 Immunofluorescence 
Cells were fixed in either 4% formaldehyde (for actin staining) for 
15 min or ice-cold 100% methanol (for GAPDH staining) for 5 min. Post 
fixation, the cells were incubated in blocking buffer (1% bovine serum 
albumin(BSA)/10% normal goat serum/0.3M glycine in 0.1% PBS-tween) 
for 1 hour. For GAPDH staining, the cells were then incubated with 
GAPDH antibody (cat. no. #ab9484, Abcam, MA, US) prepared at 10 
µg/ml in blocking buffer for 12 hours at 4°C. Subsequently, the cells were 
washed and incubated with a solution of secondary antibody (cat. no. 
#ab96789, Abcam) and DAPI (for staining the nuclei) in 1% BSA-0.1% 
PBS-tween for 1 hour. Thereafter, the cells were washed with PBS and 
imaged using a fluorescent microscope. For actin staining, the cells were 
incubated with phalloidin (cat. no. #A12379, Invitrogen) and DAPI for 1 
hour in blocking buffer. Afterwards, the cells were imaged using the 
fluorescent microscope.  
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3.2.6 Finite element (FEM) simulations of electric field intensity  
FEM simulations were performed in COMSOL Multiphysics V3.4 
(COMSOL, CA) to simulate the electric field intensities generated around 
the microelectrodes in response to voltage application. To accomplish this, 
a 3D model of the microelectrodes (three sizes 200 µm, 100 µm and 50 µm 
in diameter) and the surrounding buffer (conductivity of 1.6 S/m) was 
generated in COMSOL. The model was solved after the application of a 
fine mesh and the appropriate boundary conditions. The electric field 
intensities were plotted for the top view of microelectrodes.  
 
3.2.7 Statistical analysis 
The mean and standard deviations of the GAPDH silencing data 
were analyzed using a two-sided t-test, with a level of significance set at    
P < 0.05. 
 
3.3 Results 
 
3.3.1 ITO based MEA and site-specific electroporation 
The micro-patterning of the conductive ITO layer on glass substrate 
and the use of parylene as an insulation layer provided the MEA with a 
transparent biocompatible substrate for cell growth and site-specific 
electroporation (Figure 10(b)), which is highly desirable in cell culture 
based experiments. As seen in Figure 10(c), the bright-field image of HeLa 
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cell culture on an ITO MEA provides greater detail about the cell 
morphology when compared to a cell culture on a silicon-based MEA. 
Images in Figure 10(c) were captured using a standard upright microscope 
and in both MEAs (ITO and silicon), magnifications higher than 100X 
(10X objective) could not be achieved due to the presence of 1 cm high well 
on the MEAs. However, the compatibility of the ITO MEA with the 
inverted microscope enabled imaging at higher magnifications upto 400X 
(Figure 10(d)). In the case of inverted microscopes, the working distance 
was limited by the thickness of the glass substrate (0.8 mm).  
To evaluate the site-specific control over delivery of biomolecules 
and to determine the optimal pulse parameters for microscale 
electroporation, a series of experiments were performed with propidium 
iodide (PI), a cell impermeant nuclear stain, as a probe molecule. Figure 
11(a) shows a view of cells on a MEA both pre- and post-electroporation.  
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Figure 11. (a) Electroporation scheme. The white arrows point to 
electrodes targeted for electroporation. After application of electric pulse, 
cells on targeted electrodes fluoresce red due to uptake of PI. (b) A live 
assay performed after electroporation shows cell viability for a 4 V, 10 
msec pulse. White circle marks the electrode boundary. (c) 
Electroporation efficiencies for the three electrode sizes at electroporation 
pulse amplitudes of 3, 4, and 5 V and fixed duration of 10 msec (N=3).  
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Here, the uptake of PI molecules, indicated by red fluorescence, was 
limited to cells on targeted electrodes. It was observed that region of 
electroporation was highly specific to surface area above the electrode. 
Post-electroporation, the viability of electroporated cells was determined 
by performing a live assay on the cells. Cells that were successfully 
electroporated and remained viable appear as stained by both PI (red 
fluorescence) and live assay (green fluorescence), as shown in Figure 11(b). 
However, cells that died due to electroporation were stained only by PI. To 
determine the optimal electroporation electric pulse parameters, anodic 
voltage pulses with amplitudes ranging from 3V to 10 V and pulse 
durations of 1 msec and 10 msec were evaluated for their electroporation 
efficiencies. The electroporation efficiency was estimated by dividing the 
number of cells that were electroporated and alive divided by the total 
number of cells on the electrode. The viability was estimated as the 
percentage of cells alive on the electrode.  For the 100 µm electrode, the 
highest electroporation efficiency for the 1 msec and 10 msec duration 
pulses for PI were determined to be 90±9.4% and 77.7±9.7% (N=3) at 7 V 
and 4 V, respectively (Appendix B). At voltage amplitudes higher than 4 V 
for 10 msec pulse and 7 V for 1 msec pulse, although the percentage of total 
number of cells electroporated increased, the electroporation efficiencies 
decreased due to a decrease in cell viability (Appendix B). In all the 
experiments, a single anodic voltage pulse was applied for electroporation. 
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The anodic voltage pulse was used to facilitate the delivery of polar 
molecules such as siRNA and GFP plasmid(Golzio, Teissié, & Rols, 2002) .   
 
3.3.2 Impact of electrode size on electroporation efficiency 
In this study, MEAs with electrodes consisting of three different 
sizes of diameters (50µm, 100µm and 200µm) were patterned to 
demonstrate that the number of cells targeted for electroporation can be 
controlled by controlling the size of the electrode, as shown in Figure 
10(b). However, it was observed that the optimal electroporation 
efficiencies for the three electrode sizes were dependent on the size of the 
electrodes. Figure 11(c) shows the plot for electroporation efficiencies for 
the three electrode sizes at three different voltage pulse amplitudes (3 V-5 
V) and a pulse duration of 10 msec. As seen in Figure 11(c), at the optimal 
electroporation pulse (4 V and 10 msec), the electroporation efficiencies 
for 50 µm, 100 µm and 200 µm electrodes were found to be 100%, 
77.7±9.7% and 61.7±12.3% (N=3), respectively. In order to understand the 
observed inversely proportional relationship between the size of the 
electrode and the electroporation efficiency, FEM simulations of electric 
field (EF) intensities for the three electrode sizes were performed in 
COMSOL v3.4. The simulation results showed that the distribution of EF 
intensity over the surface of the electrodes is non-uniform, with regions of 
high intensities along the edges of the electrode and low intensities at the 
center of the electrodes (Figure 12(a)).  
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Figure 12. Electric field simulation for three electrode sizes. (a) Top view 
of the electric field intensity distribution over the surface of electrodes.   
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Simulation results are shown for three different electrode sizes (50, 100 
and 200 µm in diameter). (b) Show a plot of the electric field intensity 
along the diameter of the electrodes. (c) An image of HeLa cells on 200 µm 
electrode after electroporation with a 5 V, 10 msec pulse, showing cell 
death at the edge of the electrode. The white circle marks the electrode 
boundary and the blue circle highlights the cells on the center of the 
electrode.  
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A plot of EF intensity along the diameter of the three electrodes 
(Figure 12(b)) shows that maximum change in EF intensity from the edge 
of the electrode to the center of the electrode was proportional to the size 
of the electrode. On the 200 µm electrode, the EF intensity at the edge of 
the electrode was more than two times as strong when compared to the 
center of the electrode. The above described FEM simulation results 
indicate that cells adhered on large diameter electrodes, such as 200 µm, 
experience a varying degree of electro-permeabilization depending on 
their location on the electrodes.  The areas of high field intensities on the 
200 µm electrodes (at the edge of the electrodes) lead to cell death, 
thereby negatively impacting the electroporation efficiency. Figure 12(c) 
shows the image of a 200 µm diameter electrode with HeLa cells after 
electroporation with a 5V, 10 msec pulse. It can be observed that cells at 
the edge of the electrodes are electroporated but dead, whereas the cells at 
the center of the electrodes are electroporated and alive, as predicted by 
the EF intensity simulation.  
 
3.3.3 Site-specific gene delivery and silencing 
To demonstrate the applicability of the ITO MEA for site-specific 
transfection, HeLa cells adherent on the ITO MEA were targeted for 
electroporation in the presence of GFP plasmid and Alexa 488 tagged 
scrambled sequence of siRNA (Alexa 488 – siRNA), separately, using an 8 
V, 1 msec pulse. Figure 13(a) shows an image of HeLa cells on ITO MEA 
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expressing GFP, 24 hours after transfection with GFP plasmid, and Figure 
13(b) shows the image of HeLa cells 4 hours after transfection with Alexa 
488 – siRNA. Transfection efficiencies (TE) for the GFP plasmid and Alexa 
488 – siRNA on a 100 µm electrode for an 8 V, 1 msec anodic pulse were 
found to be 55.1±14.8% and 25.6±10% (N=5), respectively (Figure 13(c)). 
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Figure 13. (a) Image shows GFP expression in HeLa cells on targeted 
electrodes 24 hours after transfection. (b) Image of HeLa cells on targeted 
electrodes transfected with Alexa 488-siRNA. (c) Comparison of 
transfection efficiency for three molecules with different sizes (PI, siRNA 
and GFP plasmids) (N=5) (d) A boxplot displaying the variability in the 
siRNA and PI intensity among different cells on one electrode. White 
circles mark the electrode boundary. 
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 Here, the TE is defined as the percentage of cells transfected, with GFP or 
siRNA, and alive on a given electrode. The low TE for siRNA and GFP as 
compared to the PI molecules (Figure 13(c)) can be attributed to the size 
and charge of the molecules. In electroporation based delivery, the size of 
the probe molecule has been shown to be a strong determinant of the 
TE(He, Chang, & Lee, 2007) .  Larger polar molecules, such as GFP and 
siRNA, require larger pores that need to remain open longer for 
electrophoretic migration into the cell cytoplasm.  
Observation of transfection results of HeLa cells with Alexa 488 – 
siRNA indicated a variation in the level of fluorescence intensity among 
cells on a targeted electrode (Figure 13(b)), indicating a variability in the 
level of siRNA uptake amongst different cells on the same electrode. This 
variability in the level of transfection was quantified by determining the 
level of fluorescence (mean intensity) of each cell on an electrode, targeted 
for delivery of either Alexa 488 – siRNA or PI, and then plotting it as a box 
and whisker plot, as shown in Figure 13(d). The data was plotted for a 
sample size of 18 cells per electrode for both siRNA and PI. The median of 
the siRNA and PI fluorescence intensity were normalized to 1 for the 
purpose of comparison. The interquartile range (IQR) for the Alexa 488 – 
siRNA (IQR = 0.66) was found to be 2.54 times larger than PI (IQR = 
0.26); this indicates that the variability in the level of transfection amongst 
cells was higher for siRNA than for PI. The average fluorescence intensity 
of the cells with Alexa 488 – siRNA in the 3rd quartile was 1.36 times more 
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than the average fluorescence intensity of the 1st quartile. The cells in the 
highest quadrant were 3.55 times more fluorescent than the cells in the 
lowest quadrant; this demonstrates that 25% of the total cells on the 
electrode had siRNA levels greater than 3 folds in comparison to the 25% 
of the cells with the lowest fluorescent intensity.  
To evaluate the efficacy of gene silencing using the MEA based 
platform, siRNA against an endogenous gene, GAPDH, was delivered to 
targeted HeLa cells.  Here, two controls were established on the same 
device, one with siRNA against GFP (control siRNA) and one with no 
electroporation. Twenty-four hours post transfection, an 
immunofluorescence assay was performed to assess the level of GAPDH. 
Figure 14(a) shows the results of GAPDH silencing in HeLa cells 24 hours 
after transfection with GAPDH siRNA. As seen in Figure 14(a), the level of 
GAPDH in the cells transfected with GAPDH siRNA is much lower in the 
cells transfected with control siRNA.  Cells transfected with GAPDH 
siRNA showed a 52% reduction in GAPDH level (Figure 14(b)) and cells 
transfected with control siRNA showed a slight reduction (7.4%), albeit 
statistically insignificant, in GAPDH levels when compared to control cells, 
probably due to some cell death at electroporation. The viability at the 8 V, 
1 msec pulse was found to be 83.4±7.9% (N=3).  
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Figure 14. (a) Figure shows GAPDH immunostained image of HeLa cells 
on two electrodes targeted with GAPDH siRNA and control siRNA. Cell 
nuclei are shown by DAPI stain. White circles mark the electrode 
boundary. (b) Figure shows mean fluorescence intensity of GAPDH on 
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electrodes with control cells, cells targeted with control siRNA and 
GAPDH siRNA (N=6).  
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3.3.4 Actin disruption and reorganization post electroporation 
To demonstrate the utility of MEA for assessment of sub-cellular 
phenotypes, the impact of microscale electroporation on F-actin filaments, 
a key cytoskeletal protein, was investigated. In this study, the MEA was 
used to specifically look at the disruption and reorganization of F-actin 
filaments in response to microscale electroporation in adherent HeLa 
cells. Experimentally, predetermined electrodes (100 µm) on a single MEA 
were targeted for electroporation at five different time points (8 hours, 4 
hours, 2 hours, 1 hour and 5 min) prior to fixation and staining for F-actin. 
An electrode with no electroporation was established as a control. 
Electroporation was carried out by applying the optimal voltage pulse of 8 
V and 1msec to the targeted electrodes in the presence of electroporation 
buffer. The capability of MEA to perform multiple independent 
experiments enabled temporal analysis of actin filaments disruption and 
its subsequent reorganization in response to electroporation, as shown in 
Figure 15. It was observed that up to 2 hours after electroporation, HeLa 
cells sustained a disruption in the structural composition of the actin 
filaments, characterized by the aggregation of actin filaments at the cell 
periphery and the dissolution of fine fibers traversing the cytoplasm 
(Figure 15). The microfilaments reorganized to their original state within 4 
hours of electroporation (Figure 15).  Interestingly, up to 5 minutes after 
electroporation (Figure 15), the actin filaments remained intact indicating 
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that the disruption of microfilaments in HeLa cells did not occur 
immediately after or during electroporation.  
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Figure 15. Disruption and subsequent reorganization of actin filaments in 
HeLa cells at different time points after electroporation. White circles 
mark the electrode boundaries. 
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3.4 Discussion and Conclusion 
A major advantage of the MEA based system is the precise control 
over the region of electroporation, derived from the spatial arrangement of 
the electrodes in the MEA, which is highly desirable in high-throughput 
screening. The combined spatial and temporal control demonstrated by 
the MEA based system allowed multiple experiments to be performed on 
the same culture, thereby decreasing the culture-to-culture variability and 
increasing the experimental throughput. In addition, compatibility with 
imaging based assays is highly desirable in cell based experiments. 
Traditional MEAs are opaque in nature and hence are mostly compatible 
with only upright microscopes. In addition, the presence of a well mounted 
on MEA for containing the cell media severely restricts the working 
distance of an objective lens, making it difficult to image at high 
magnifications (>10X objectives). The optically transparent nature of the 
ITO MEA makes it compatible with both upright and inverted 
microscopes. The thickness of the glass substrate can potentially be 
reduced to 200µm, allowing magnifications higher than 400X and 
confocal microscopy. Alternatively, incorporation of microfluidics can 
potentially reduce the height of the well to under 1 mm, allowing higher 
magnifications using an upright microscope. In any scenario, the ITO 
MEA allows brightfield imaging of cells which enables morphological 
assessment of modified cells.  
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It is well known that electroporation of a cell occurs when the 
strength of the applied EF exceeds a certain threshold value (Gehl, 2003). 
Reversible electroporation is possible only for a narrow range of EF 
intensities above the threshold value; at EF intensities higher than the 
reversible range, cell death occurs due to severe irreversible damage to the 
cell membrane. FEM simulations of EF intensity have been previously 
used to predict regions of successful transfection and regions of cell death 
for various electrode shapes and configurations (W. C. Chang & Sretavan, 
2009; Dong-yang, Cheng-xiang, Yan, & Chen-guo, 2008; H. Huang et al., 
2010; Jain & Muthuswamy, 2007a; Jain & Muthuswamy, 2007b). In this 
study, the FEM simulation of the EF intensity distribution on the surface 
of the electrodes with three different sizes assisted in identification of 
potential regions of reversible and irreversible electroporation on the 200 
µm electrode surface. The simulation results correlated well with the 
experimental observations (Figure 12(c)) in providing the explanation for 
the lower transfection efficiencies on the 200 µm electrode when 
compared to the 100 µm and 50 µm electrodes. The low electroporation 
efficiency of large diameter electrodes (>200 µm) is a major disadvantage 
in applications that require transfection of a large number of cells per 
single site.  An alternative approach to overcome this limitation would be 
to use multiple smaller electrodes patterned close to each other, allowing 
electroporation of a large number of cells in a targeted region. In addition, 
for applications that require single cells targeting, electrodes in the order 
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of a few microns can be patterned. Furthermore, electrodes could be 
patterned to micron or sub-micron diameters to target specific regions of 
single cells (Hai & Spira, 2012). 
The siRNA transfection experiments demonstrated the applicability 
of the ITO MEA for site-specific gene silencing. It was observed that a 
certain degree of variability existed in the level of transfection each cell 
experienced on targeted electrodes. The variability in the level of siRNA 
transfection among different cells on an electrode is a common limitation 
in the majority of the transfection techniques. However, the effect of 
variation in gene silencing can be minimized by averaging the gene 
silencing results over multiple electrodes. In particular to microscale 
electroporation, the possible causes for the variability in the siRNA uptake 
include intrinsic factors such as, the state of each cell, cell shape and/or 
extrinsic factors such as non-uniform distribution of electric field on the 
electrode. A strategy that can be employed to overcome the extrinsic 
factors includes optimizing the shape and size of the electrode to deliver a 
highly uniform electric field distribution over the target region(H. Huang 
et al., 2010). In addition, simulations and experimental studies 
investigating the interaction of cell shape and size with electric field are 
also necessary to fully understand and predict the level of membrane 
permeabilization experienced by each cell (Agarwal et al., 2007). This 
would enable development of adaptive systems that can realize controlled 
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permeabilization of each cell based on its shape, size and position in the 
electric field (R. Yang, Tarn, & Zhang, 2010).  
In this study, the successful site-specific transfection of HeLa cells 
with GAPDH-siRNA was demonstrated, resulting in a significant 
reduction (52%) in the level of the GAPDH 24 hours after transfection in 
comparison to control cells (Figure 14(b)). Future research will aim to 
deliver different functional siRNA at different sites in the culture and 
sequential delivery of multiple siRNA to the same site. The level of gene 
silencing depends on various factors such as cell type, dosage of siRNA, 
turnover rate for the protein, and the efficacy and stability of the siRNA 
molecules in the cytoplasm. In gene silencing experiments, it is extremely 
desirable to maintain a precise control over the dosage of siRNA delivered 
to cells. In the case of microscale electroporation, strategies that can 
potentially be implemented to gain control over the dosage of siRNA 
include controlling the concentration of siRNA in the electroporation 
buffer and sequentially repeated electroporation at different time points. 
Such a strategy would require optimization of time points between 
subsequent electroporation steps to maintain highest possible cell 
viability.  
In addition to the site-specific transfection, the applicability of the 
ITO MEA was also demonstrated in investigating the functional impact of 
electroporation on cells. For instance, in electroporation mediated cell 
transfection, the cytoskeleton of the cells is thought to play an active role 
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in the transfer of genetic payload through the cell membrane and into the 
cytoplasm (Kanthou et al., 2006; Rosazza, Escoffre, Zumbusch, & Rols, 
2011; Teissie & ROLS, 1994). Electroporation has also been shown to have 
a reversible effect on the structural organization of the cytoskeleton 
microfilaments, which may in part be responsible for the observed 
interaction of the cytoskeleton with the genetic material (Kanthou et al., 
2006). In order to achieve high transfection efficiencies, it is imperative to 
fully understand the involvement of cytoskeleton in gene transfer. In a 
study by Rosazza et al., the role played by actin filaments in the transfer of 
DNA plasmid molecules across the cell membrane was investigated 
(Rosazza, Escoffre, Zumbusch, & Rols, 2011). The study found that DNA 
molecules interacted with actin filament patches in the membrane 10 
minutes after electroporation in chinese hamster ovary cells. This 
interaction was also found to assist the translocation of DNA molecules 
through the cell membrane. Thus, it is plausible that the disruption of 
actin filaments post electroporation mediates the transfer of DNA 
molecules to the cytoplasm; however, the underlying phenomenon of actin 
filaments disruption due to electroporation and its impact on cell 
functioning remains unknown.  The actin experiments performed here 
served a dual purpose of establishing the applicability of the MEA for 
assessment of sub-cellular phenotypes and to perform preliminary 
experiments using the MEA towards understanding the impact of 
microscale electroporation on the cell cytoskeleton and the mechanism of 
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DNA transfer to the nucleus in adherent cells. The experiment results 
showed that actin filaments get disrupted post-electroporation and sustain 
the disruption for up to 2 hours before reorganization occurs.  
In this study, a scalable ITO based MEA was fabricated for site-
specific delivery of genetic material in adherent cells. Successful gene 
silencing and exogenous plasmid expression in targeted cells was 
demonstrated 24 hours after transfection. In addition, it was determined 
that electroporation efficiencies are influenced by the size of the 
electrodes, with small electrodes (≤ 100 µm) offering the highest 
efficiency. The technology presented here offers a cost-effective approach, 
which is highly suited for primary cells lines such as neurons, for high-
throughput genetic studies.   
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CHAPTER 4 
A NEURO-CHIP FOR SIMULTANEOUS DELIVERY OF NUCLEIC ACIDS 
AND ASSESSMENT OF FUNCTIONAL CHANGES IN TARGETED 
NEURONS IN CULTURE 
 
4.1 Introduction 
Genetic intervention techniques such as gene silencing (RNA 
interference) and gene expression (plasmid vectors) offer a powerful 
approach to determine function of genes that are implicated in 
neurological disorders, neuronal differentiation and regenerative medicine 
(Friedmann, 1994; Poole, Bashllari, Cochella, Flowers, & Hobert, 2011; Y. 
Yao, Wang, Varshney, & Wang, 2009). However, a major challenge in the 
above applications is the efficient delivery of siRNA molecules or plasmid 
vectors to spatially targeted neuronal populations (Krichevsky & Kosik, 
2002; Whitehead, Langer, & Anderson, 2009). A majority of the current 
non-viral transfection methods such as chemical transfection (Lonez, 
Vandenbranden, & Ruysschaert, 2008; Park, Jeong, & Kim, 2006), bulk 
electroporation(Dityateva et al., 2003; McCall, Nicholson, Weidner, & 
Blesch, 2012; Prasanna & Panda, 1997), and nanoparticles assisted 
delivery (Bonoiu et al., 2011; Ghosh, Han, De, Kim, & Rotello, 2008), lack 
precise spatial control over delivery. Targeted delivery of genetic material 
is particularly desirable in a heterogeneous cell population, such as the 
nervous system, where delivery to non-targeted cell types can elicit 
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unwanted responses (Matthaei, 2007).  In addition, site-specific 
transfection in network forming cells, such as neurons, enables 
investigation of cell-network interactions (L. Luo, Callaway, & Svoboda, 
2008; Takahashi et al., 2011). Furthermore, high-throughput miniaturized 
genetic screening platforms can greatly benefit from precise spatio-
temporal control over delivery of nucleic acids (Wheeler, Carpenter, & 
Sabatini, 2005). For example, the transfected cell microarrays technique 
developed by Ziauddin and Sabatini more than a decade ago, enabled site-
specific transfection of cells in a culture in a microarray fashion allowing 
screening multiple genes in a single cell culture grown on a glass slide 
(Ziauddin & Sabatini, 2001). However, in addition to lack of temporal 
control over transfection, a major limitation with this technique is its 
reliance on chemical based transfection which offers low transfection 
efficiency in primary cell lines such as neurons. Since then advances in 
microfabrication techniques have led to development of several 
miniaturized platforms that utilize microscale electroporation as a method 
for transfection (Boukany et al., 2011; W. C. Chang & Sretavan, 2009; Hai 
& Spira, 2012; K. S. Huang, Lin, Su, & Fang, 2006; Y. Huang & Rubinsky, 
2001; Inoue, Fujimoto, Ogino, & Iwata, 2008; Jain & Muthuswamy, 
2007a; Jain & Muthuswamy, 2007b; Jain & Muthuswamy, 2008; Jain, 
Papas, Jadhav, McBride, & Saez, 2012; W. G. Lee, Demirci, & 
Khademhosseini, 2009; Y. C. Lin, Li, Fan, & Wu, 2003; Movahed & Li, 
2011; Olbrich, Rebollar, Heitz, Frischauf, & Romanin, 2008; Stett et al., 
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2003; Valero et al., 2008; Valley et al., 2009; Y. Xu, Yao, Wang, Xing, & 
Cheng, 2011). Microscale electroporation has been shown to offer high 
transfection efficiency in primary cell lines and it enables precise spatial 
and temporal control over transfection. In the above mentioned platforms, 
microscale electroporation is typically achieved by utilizing 
microelectrodes to generate localized electric field intensity patterns that 
allows spatially targeted electroporation of cell membranes of single cells 
and sub-cellular structures. Traditionally, microelectrode arrays have been 
used in neurophysiology for stimulation and measurement of electrical 
activity of cells (Stett et al., 2003). Electrical activity of neurons is one of 
the most widely preferred methods to assess neuronal function. Therefore, 
technology that integrates the ability to simultaneously deliver genetic 
material and measure electrical activity of precisely targeted neurons in a 
high-throughput fashion will enable the assessment of the impact of gene 
manipulation on the function of neurons in real time at the level of single 
cell and the entire network.  
Based on the above premise, the use of patterned micro-electrode 
array (MEA) based platform for targeted transfection of primary neurons 
and NIH 3T3 cells in culture has been demonstrated (Jain & 
Muthuswamy, 2007a; Jain & Muthuswamy, 2007b; Jain & Muthuswamy, 
2008). In the above approach, the MEA is used to induce electroporation 
in a targeted group of cells in a culture and simultaneously utilize the same 
electrodes to monitor electrical activity of single neurons. However, a 
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major limitation with traditional MEAs is the optically opaque nature of 
the electrodes and/or substrate that restricts imaging which is a crucial 
necessity for various biological assays, especially in high-throughput and 
high-content genetic studies (Wheeler, Carpenter, & Sabatini, 2005). In 
this study, the application of an optically transparent MEA for spatially 
and temporally controlled transfection of primary hippocampal neurons in 
a culture was demonstrated. Secondly, targeted transfection of genetic 
payloads of different sizes and molecular characteristics, such as GFP 
plasmids and fluorescently tagged siRNA molecules (Alexa 488-siRNA), 
was successfully demonstrated for the first time in a primary culture of 
hippocampal neurons. Additionally, the impact of electroporation itself on 
spontaneous electrical activity of neurons was assessed. Finally, this work 
reports for the first time delivery of GFP plasmids to neurons through 
electroporation of neuronal processes.  
 
4.2 Materials and Methods 
 
4.2.1 MEA fabrication 
The neuro-chip was fabricated using standard 
microelectromechanical systems (MEMS) based process. The MEA was 
patterned in indium-tin oxide (ITO), a transparent conductive material, on 
a glass substrate. A thin layer of parylene was deposited on the MEA as an 
insulation layer. The parylene layer was selective etched using oxygen 
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plasma to expose the microelectrodes and the bond pads. The MEA 
consisted of 32 circular microelectrodes, each with a diameter of 100 µm. 
Figure 16(b) shows a picture of the neuro-chip with a well containing cell 
media placed on the MEA.  
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Figure 16. (a) Experimental setup. (b) Image of the MEA with well 
containing media. (c) Connector for neural recording. (d) 4 DIV culture of 
E18 hippocampal neurons on the ITO MEA. 
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4.2.2 Electrical characterization of the MEA 
The electrical characterization of the microelectrodes was 
conducted using an electrochemical workstation (Model 660a, CH 
instruments, TX, USA). The electrical impedance spectroscopy (EIS) was 
carried out in the presence of phosphate buffered solution (PBS) with the 
microelectrodes as working electrodes and platinum wire as the reference 
and counter electrode. A frequency sweep of 100 Hz -100,000 Hz was 
performed for the EIS measurements. The integrity of the interconnect 
traces and the microelectrodes was determined by examining the EIS 
results. Electrodes with discontinuous traces and/or unexpectedly high 
impedances were excluded from the experiments.  
 
4.2.3 MEA preparation and cell culture 
The parylene insulation layer on the MEA is naturally hydrophobic 
in nature. In order to make the MEA surface hydrophilic, it was treated 
with oxygen plasma for 1 – 2 min. Afterwards, the MEAs were coated with 
poly-D-lysine (PDL) at a concentration of 100 µg/ml for a period of 12 h at 
room temperature in a sterilized flow hood to facilitate cell adhesion. Prior 
to cell seeding, the MEAs were treated with laminin (20 µg/ml) for 20 – 
30 min.  The E18 hippocampal neurons for culture on the MEA were 
obtained from Brainbits, LLC (Springfield, IL). On the day of cell seeding 
the E 18 hippocampal tissue was digested in 2 ml of 2 mg/ml sterilized 
papain (Sigma Aldrich, St. Louis, MO) in Hibernate-E without CaCl2 
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(Brainbits. LLC, Springfield, IL) for 30 mins at 34°C. Post digestion, the 
tissue was washed and dissociated in Hibernate-E media by trituration 
(10X) using a standard 1000 µl pipet tip. Next, the cells were pelleted by 
spinning at 200 RCF for 4 mins. The cells were then raised to a 
concentration of 1000 – 3000 cells/µl in Nbactiv-1 media (Brainbits. LLC, 
IL), depending on the desired seeding concentration. A 25 – 30 µl drop of 
cells was then placed on the center of MEA and the cells were allowed to 
adhere for 2 h in a humidified incubator maintained at 37°C and 5 % CO2. 
The cells were maintained in 600 µl of Nbactive-1 (Brainbits. LLC, IL) 
medium and half of the medium was changed every 2 – 3 days.  
 
4.2.4 Electroporation setup and imaging 
The microelectrodes were accessed for electrical stimulation by 
using a dual-inline-package (DIP) clip to connect the bond pads of the 
MEA with a function generator (2414A, Pragmatic. Inc., Geneva, OH). 
Prior to each electroporation experiment, the function generator was 
configured to output a single anodic square pulse with desired pulse 
amplitude and duration. Individual access to the microelectrodes was 
achieved by using an 8 switch demultiplexor board that connected to the 
output of the function generator. For the ground, a sterilized steel 
electrode was lowered into the MEA well and was positioned 1 mm above 
the surface of the MEA. Imaging of cells on the MEA was carried out using 
an inverted fluorescence microscope.  
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4.2.5 Experimental protocol  
Figure 16(a) shows the experimental setup. The electroporation 
experiments were typically performed on a 4-5 day old neuronal culture. 
By this time the neurons were typically differentiated and the processes 
have formed (Figure 16(d)). On the day of the experiment, a 200 – 300 µl 
solution of probe molecule in electroporation buffer (#165-2677, Bio-rad, 
Hercules, CA) was prepared and maintained at 4°C. The three different 
probe molecules used in experiments were, propidium iodide, alexa-488 
conjugated scrambled sequence siRNA (#1027992, Qiagen, Inc., Valencia, 
CA), and GFP plasmids; these molecules were prepared at 50 µg/ml, 2.5 
µM, and 50 µg/ml respectively. Prior to the electroporation of cells, the 
media in the MEA well was replaced with the ice-cold electroporation 
buffer containing the probe molecule. Immediately afterwards, the MEA 
was connected with the function generator via the DIP clip and 
multiplexor board. Next, electric pulses for electroporation were applied to 
the desired microelectrodes.  Upon completion of voltage pulse 
application, the MEA was transferred to the incubator. After a 10 min 
incubation period, the electroporation buffer in the MEA well was replaced 
with pre-warmed and CO2 equilibrated media. For PI experiments, a live 
assay was performed on the cells 2 – 4 h after electroporation to determine 
the viability of cells. In the case of PI and alexa-488 conjugated siRNA 
experiments fluorescent imaging was done 4 h after electroporation and in 
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the case of GFP transfection, cells were imaged 24 h after electroporation. 
The electroporation efficiency was calculated as the percentage fraction of 
total number of viable cells loaded with PI. The transfection efficiency for 
alexa-488-siRNA and GFP was calculated as the percentage fraction of the 
total number of cells displaying uptake of siRNA or expressing GFP.  
 
4.2.6 Neuronal recordings 
A custom made connector with spring loaded pins (Figure 16(c)) 
was used to connect the MEA with a data acquisition system (MAP system, 
Plexon, Inc., Dallas, TX) for measuring the electrical activity of neurons.  
The MEA was maintained in the incubator during recording sessions. 
Recording sessions were performed in 10 min intervals. The spike data 
was analyzed in Offline sorter v2.8.8 (Plexon, Inc., Dallas, TX) and 
Neuroexplorer (Plexon, Inc., Dallas, TX). Typically, neural activity was 
observed after 7 days of culture or days in vitro (DIV). 
 
4.3 Results  
 
4.3.1 Optimal electroporation parameters 
The EP parameters were optimized as previously described (Patel & 
Muthuswamy, 2012). Briefly, to determine the highest transfection 
efficiency, a series of experiments were conducted to optimize the 
electroporation voltage pulse amplitude and pulse width. In all the 
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experiments, a single anodic square wave pulse was applied to the 
microelectrodes to achieve electroporation. To quantitatively assess the 
transfection efficiencies, different electroporation pulse amplitudes, with a 
constant pulse width of 1 msec, were applied to different microelectrodes 
in the presence of PI, a cell impermeable nuclei stain.  Successfully 
electroporated neurons were detected by red fluorescence due to the 
staining of nucleic material by PI. Approximately 2-4 h post 
electroporation, a calcein based live assay was conducted to determine the 
viability of neurons. A picture of the entire MEA with a 4 DIV culture of 
E18 hippocampal neurons post electroporation is shown in Figure 17(a). 
The image on the left shows PI stained neurons on microelectrodes that 
were stimulated with square wave anodic pulses of 6 V, 7 V, 8 V, 9 V, and 
10 V amplitude and the image on the right displays the result of a live 
assay performed 4 h post electroporation. A close-up image of 
microelectrodes stimulated with 7 V and 10 V pulse is shown in Figure 
17(b). 
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Figure 17. Optimization of  electroporation (EP) parameters for 
hippocampal neurons : (a) Shown in left image is targeted delivery of PI to 
neurons on a 4x8 microelectrode array (MEA) stimulated with1 msec 
anodic square pulse of amplitudes 6 V, 7 V, 8 V, 9 V and 10 V; the right 
image shows the result of live assay performed on the same neurons after 
electroporation. (b) Close-up images of two electrodes stimulated with 7 V 
and 10 V, 1 msec anodic pulses. The white arrows indicate representative 
neurons that are alive and loaded with PI. The blue arrows point to 
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neurons that are dead. The image on the left is superimposed image of live 
assay and PI. The image on the right shows PI. The white circles indicate 
the boundary of the 100 m diameter microelectrodes. (c) Electroporation 
efficiencies at different EP voltage pulse amplitudes (n=4). 
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As seen in Figure 17(b) majority of the cells on 7 V stimulated 
microelectrode stained both red and green indicating high electroporation 
efficiency in viable neurons. In contrast, neurons on the 10 V stimulated 
microelectrode displayed average viability of 48.3±16.6% (N=4) resulting 
in low electroporation efficiency. A plot of electroporation efficiencies as a 
function of voltage pulse amplitude is shown in Figure 17(c). 
Electroporation efficiencies were found to be lower when pulse voltage 
amplitudes were less than or equal to 6 V due to smaller number of 
electroporated cells.  Similarly, electroporation efficiencies were lower at 
voltage pulse amplitudes higher than 8 V but due to increased cell death. 
The highest electroporation efficiencies for neurons of 88.2±7.9 % and 
87.3±4.2% were observed consistently at pulse amplitudes of 7 V and 8 V 
respectively.  
 
4.3.2 Site-Specific transfection of GFP plasmid vectors and siRNA 
molecules 
GFP plasmid vectors and Alexa-Fluo-488 conjugated scrambled 
sequence of siRNA were transfected into neurons on targeted 
microelectrodes to evaluate the applicability of the ITO based neuro-chip 
for site-specific transfection in neuronal cultures. The transfection 
experiments were accomplished using the optimal 8 V, 1 msec anodic 
pulse. The expression of GFP in neurons on top of three microelectrodes 
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that were targeted for transfection with GFP plasmids is shown in Figure 
18(a).  
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Figure 18. Site-specific transfection of hippocampal neurons. (a) The 
images shows expression of GFP 24 h after neurons were transfected with 
GFP plasmid vectors at 4 DIV. The white arrows point to the neurons 
expressing GFP. The black arrow points to an astrocyte transfected with 
GFP plasmid. (b) The image on the left shows neurons transfected with 
Alexa-488-siRNA; the image on its right shows the result of live assay 
performed after imaging the siRNAs. The blue arrow points to a dead cells. 
In all of the above cases a 8 V, 1 msec anodic pulse was applied to 
microelectrodes for electroporation.   
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The GFP expression images were taken 24 h post transfection. The 
transfection efficiency for GFP plasmids was observed to be highly 
variable, as seen in Figure 18(a), with some microelectrodes displaying no 
more than 1 neuron transfected and some microelectrodes displaying 34 % 
of neurons transfected in the same culture. In addition, the level of GFP 
expression amongst transfected cells on the same electrode was also found 
to be variable. GFP transfection was observed both in neurons as well as 
astrocytes (Figure 18(a)). Shown in Figure 18(b) is the result of Alexa-
Fluor-488 conjugated siRNA transfection in neurons on top of two 
microelectrodes. The transfection of Alexa-Fluor-488 conjugated siRNA 
into targeted neurons caused their somas to fluoresce green. A dead assay 
was performed 4 h post-electroporation to determine viability of cells. The 
average transfection efficiency for siRNA molecules was determined to be 
greater than 60%. 
 
4.3.3 Transfection through neuronal processes 
In the analysis of the transfection assay results, the possibility of 
transfection occurring through neuronal processes adhered on top of 
targeted microelectrodes was discovered. Figure 19(a) shows brightfield, 
PI fluorescence and live assay images of a 4 DIV culture of hippocampal 
neurons on an electrode stimulated with 7 V, 1 msec pulse. 
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Figure 19. Transfection of neurons through localized electroporation of 
neural processes. (a) The figures here show neurons with cell bodies 
outside the electrode region but with axons on the electrode pulsed with a 
7 V, 1 msec pulse display uptake of PI, indicating electroporation of axons. 
The blue arrows point to the neural processes on the electrodes. The white 
arrows point to the neurons outside the electrodes that fluoresce red due 
to the uptake of PI. (b) At the same distance away from the electrode, 
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different regions show different number of neurons with PI. The white 
circle (in broken lines) is showing a region next to the microelectrode 
where majority of the total neurons display an uptake of PI whereas the 
blue circle (in broken lines) is showing a region next to the microelectrode 
where only a few of the total viable neurons display an uptake of PI. (c) A 
plot of electroporation efficiency in the neighboring region of the 
microelectrode as a function of distance from the edge of the 
microelectrode. (d) The figure displays the result of GFP transfection of 
neurons through process. The blue arrows show the processes of 
transfected neurons and the white arrows show the somas of the 
transfected neurons.  
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It can be observed that the three neurons indicated by the blue 
arrows (Figure 19(a)) are viable and present outside the region of the 
targeted electrode. However, contrary to expectation the three neurons 
were found to be successfully electroporated, as indicated by red 
fluorescence of nuclei due to the PI uptake, upon stimulation of the 
electrode. Interestingly, the processes of the electroporated neurons can be 
clearly seen on top of the targeted microelectrodes (shown by white 
arrows). This indicates the possibility of electroporation induced 
transfection occurring at the level of subcellular structures for the same EP 
pulse parameters that lead to electroporation of cell bodies. In Figure 
19(b) the PI electroporation assay of an electrode stimulated with 7 V, 1 
msec pulse shows that electroporation of neurons was observed up to as 
far as 150 µm from the edge of the stimulated microelectrodes. The plot in 
Figure 19(c) displays the transfection probability of a neuron as a function 
of its distance from the edge of the microelectrode (up to 100 µm from the 
edge of the electrode) using 7 V, 1 msec voltage pulses. The average 
probability of neuron being electroporated dropped below 50 % at a 
distance of 25 µm from the edge of the microelectrode and remained as 
high as 30 % upto a distance of 100 µm from the edge of the 
microelectrode. An alternative explanation for the electroporation of 
neurons outside the region of targeted microelectrodes is the presence of 
strong fringe electric field intensities away from the edge of the electrode.   
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In order to assess the presence and impact of fringe electric field 
intensities beyond the boundaries of the electrode, electroporation of 
HeLa cells cultured on the MEA was performed. HeLa cells were used 
because they covered the MEA surface completely upon reaching 
confluency thereby enabling an accurate assessment of electroporation 
efficiency away from the edge of the microelectrode. In addition, HeLa 
cells lacked processes, thus any electroporation observed outside the 
electrode region can be attributed to the presence of fringe electric field 
intensities beyond the electrode boundaries. Appendix B shows the 
transfection assay of HeLa cells on an electrode stimulated with 8 V, 1 
msec EP pulse. It can be clearly seen that electroporation was strictly 
confined to a region of 10 µm beyond the edge of the electrode. This 
strongly suggests the uptake of PI by neurons beyond 10 µm from the edge 
of the microelectrodes is most likely due to electroporation of the 
processes of those neurons on the stimulated microelectrode; the 
electroporation of the dendrites or axons allow the entry of PI molecules 
and is transported to the cell bodies where it stains the nucleic material. 
Transfection of neuronal processes was also observed for large molecules 
such as GFP plasmids indicating a possibility of transfection of neurons 
through the electroporation of axons, as seen in Figure 19(d); the two cells 
indicated by the blue arrows with axons running on neighboring 
microelectrodes (indicated by white arrows) both displayed an expression 
of GFP 24 h after transfection with GFP plasmids.  
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4.3.4 Neuronal recordings 
EIS results for ITO microelectrodes on the neuro-chip are shown in 
Figure 20(a) for a frequency sweep of 100 Hz to 100000 Hz.  The 
impedance of 100 µm microelectrodes at 1 kHz was in the range of 379.1 
±14.0 kohm (N=4). Although, the impedance of ITO microelectrodes is 
comparatively higher than typical gold or iridium oxide coated 
microelectrodes, it is acceptable for measuring neural activity in vitro. The 
phase plots for the 100 µm ITO microelectrodes show in Figure 20(a) 
indicates that the phase is capacitive in nature for frequencies of the 
expected neural signal spectra. An example of unit activity recorded from a 
10 DIV hippocampal culture is show in Figure 20(b).  
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Figure  20. Electrochemical impedance spectroscopy (EIS) 
characterization of electrodes and sample unit activity (a) The top figure 
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shows the impedance of the microelectrodes versus frequency and the 
bottom figure shows the phase versus frequency. (b)  The top figure shows 
the typical unit activity from a 10 DIV hippocampal culture from one 
electrode. The bottom figures show the corresponding ISI for the units.  
 
  
  106 
The neuronal cultures on the MEA were fully differentiated by 4 
DIV and the electrical activity could be recorded by 7 DIV. To validate the 
applicability of the neuro-chip for functional assessment of neurons, the 
effect of electroporation on neural activity was evaluated. To accomplish 
this, two 10 min recording sessions were performed for 16 
microelectrodes, one 15 min prior to and one 15 min post-electroporation; 
an 8 V, 1 msec anodic voltage pulse was applied to all the 16 
microelectrodes to achieve electroporation. The experiment was carried 
out on a 10 DIV E18 hippocampal culture. In this experiment, the goal was 
to determine the impact of one voltage pulse used for electroporation on 
the electrical excitability of neurons. Figure 21(a) shows the mean firing 
rate (spikes/min) per channel (microelectrode) for 10 min recording 
sessions prior to and post-electroporation; data is shown only for the 7 
channels that displayed neuronal activity. The temporal profile of the 
electrical activity for the 10 min recording sessions is shown in Figure 
21(b) for channels 10, 11, 12 and 14. Neurons in channels 10 and 14 
displayed a statistically significant decrease in the electrical activity of 
neurons post electroporation, while neurons in channels 11 and 12 showed 
a statistically significant increase in the firing rate. Remaining channels 
showed no statistically significant change in their electrical activity.  Data 
outside the 95% confidence interval was considered to be statistically 
significant.  
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Figure  21. Neural activity before and after electroporation. (a) The figure 
shows the average spike rate over a period of ten minutes before and after 
electroporation. (b) The figures show the temporal profile of mean spike 
rate from 4 channels (10, 11, 12, and 14) before and after electroporation. 
The black dashed lines represent the 95% confidence interval.  
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4.4 Discussion and Conclusion 
In this study, the aim was to demonstrate the use of an optically 
transparent neuro-chip for precisely targeted transfection in primary 
neurons and simultaneous functional assessment of neuronal 
electrophysiology. Towards this end, an MEA was fabricated with 
microelectrodes and leads patterned in ITO on a glass substrate. The 
electroporation pulse parameters were first optimized in E18 hippocampal 
neurons using the PI/live cell assay (Patel & Muthuswamy, 2012). Second, 
the optimal pulse parameters were used to deliver GFP plasmid vectors 
and fluorescently tagged siRNA molecules into targeted neurons in a 4 
DIV culture on the MEA. Third, neurons can be transfected with plasmid 
vectors through localized electroporation of neuronal processes was 
reported. Finally, the utility of the neuro-chip for measuring electrical 
activity of targeted neurons was demonstrated.  
The development of the ITO based neuro-chip was motivated by the 
need for a high-throughput gene function assessment platform for 
neuronal studies. A major challenge with neuronal studies is consistent 
and efficient transfection of neurons. The neuro-chip overcomes this 
limitation by utilizing microscale electroporation for achieving 
transfection; microscale electroporation has been shown to deliver high 
transfection efficiency in hard-to-transfect cells lines such as neurons both 
in vivo and in vitro (W. G. Lee, Demirci, & Khademhosseini, 2009).  A 
critical step in electroporation based transfection is the optimization of the 
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electroporation parameters for each cell type. The use of PI/live 
electroporation assay provided a quick and cost effective way to determine 
the optimal electroporation pulse parameters. High electroporation 
efficiencies were observed over a range of electroporation pulse 
amplitudes (7 V to 9 V) indicating a robust and consistent electroporation, 
that is not highly sensitive to small changes in voltage amplitude.  The 
optimal electroporation parameters determined here were for 4-7 DIV 
neuronal cultures. It remains unknown if the optimal electroporation 
parameters change with the age of the culture. The electroporation 
efficiency can possibly be further enhanced by investigating effect of 
several other factors such as the constitution and conductivity of the 
electroporation buffer, number of pulses and the polarity of pulse (Hui, 
1995). A potential issue could arise from the fact that the amplitude of the 
optimal electroporation pulse, 8 V, lies beyond the water window of the 
ITO electrodes in cell culture media (-1.2 to +1.2 V).  Electrode potentials 
beyond water window can lead to hydrolysis of water and formation of 
bubbles and reactive ionic species at the electrode-media interface that can 
potentially cause irreversible cell damage or death over a period of time. 
However, no bubble formation was visually observed at the electrode-
media interface probably due to the fact that only a short duration of a 
single stimulation pulse was applied to the electrodes. Further, results of 
the cell viability assay indicated high level of survivability among neurons 
post-electroporation confirming that the potentially adverse consequences 
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of the voltage pulse amplitude exceeding the water window are minimal in 
these experiments. The above mentioned concerns can be potentially 
serious when multiple long duration voltage pulses with amplitudes 
exceeding the water window are applied to the microelectrodes.  
The successful delivery of GFP plasmid and its expression in 
targeted neurons was critical in establishing the functionality of nucleic 
acids inside the neurons after delivery. The transfection efficiency per 
electrode for GFP was found to be highly variable. However, in all the 
cases, the transfection efficiency per electrode for the GFP is higher than 
or comparable to current chemical transfection based methods. In 
addition, given the consistency seen in transfection of GFP plasmid per 
electrode, it is possible to increase the overall transfection efficiency in the 
entire culture by increasing the number of transfection sites 
(microelectrodes) in the culture. The variability in the transfection 
efficiency of smaller molecules such as siRNA and PI was much lower 
when compared to GFP molecules suggesting that the larger size of the 
GFP plasmids might be directly responsible for the variability in the 
transfection of GFP plasmids. Small molecules such as PI and siRNA can 
diffuse rapidly through the pores formed in the membrane upon 
electroporation; however, larger molecules such as GFP plasmids have 
been reported to be internalized into the cells through membrane 
interaction at the sites of pore formation post electroporation (Paganin-
Gioanni et al., 2011).  
  111 
The investigation of the role played by axons in intracellular transport and 
transmission of action potentials is of crucial significance in neuroscience 
research. In a previous study, Chang and Sretavan fabricated 
microelectrodes with vertical sidewalls that enabled localized delivery of 
EGTA to axons by electroporation (W. C. Chang & Sretavan, 2009). In a 
similar observation, electroporation of neuronal processes present on the 
surface of the stimulated microelectrodes was demonstrated. The localized 
electroporation of neuronal processes led to the entry and transport of the 
probe molecules (PI and GFP plasmids) to the cell bodies that were 
present well outside the edge of the stimulated microelectrodes. This is the 
first report of transfection of neurons with genetic constructs through 
localized electroporation of axons. However, in gene-silencing 
experiments, transfection of neurons away from the targeted site of 
electroporation can potentially lead to confounding results. The loss in 
site-specificity due to the transfection of neurons through the 
electroporation of its processes can potentially be minimized by reducing 
the size of the microelectrodes. Microelectrodes with diameters as small as 
10 µm, comparable to the dimensions of neuronal cell bodies, can be 
fabricated using standard photolithography. It is likely that siRNA 
molecules can also be transfected through neuronal processes. The entry 
of siRNA through the neuronal processes was hard to detect due to low 
fluorescence intensity of siRNA molecules. This can partly be resolved in 
future experiments by using better imaging equipment such as confocal 
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microscopy. The prospect of siRNA delivery through processes offers a 
new way to silence genes locally in targeted neuronal processes which is 
highly desirable in studies investigating the role of genes that are locally 
translated in the axons and dendrites (Hengst, Cox, Macosko, & Jaffrey, 
2006).  
The data for neuronal recording pre- and post-electroporation 
indicated that neurons at different electrodes displayed a varying response 
to electroporation (Figure 21(a)). Neuronal cultures consist of different 
excitatory and inhibitory neuronal cell types that form complex networks. 
It is likely that differing response seen at different channels was dependent 
on the type and location of targeted neurons within the network. In the 
experiments, it was difficult to determine any immediate consistent effect 
of electroporation on the neural activity as the culture was maintained in 
electroporation buffer for 10 min after electroporation. However, the MEA 
based system is ideally suited for gene-silencing experiments where long 
term recordings are desired from neurons at different transfection sites. 
RNAi is one of the most powerful gene silencing techniques and is being 
rapidly adopted in genetic screens and as a potential therapeutic tool in 
neurological disorders (Boudreau & Davidson, 2010; Krichevsky & Kosik, 
2002; Mohr, Bakal, & Perrimon, 2010). The ITO based MEA offers a novel 
approach for developing high-throughput and high-content neuronal 
studies. A key requirement of such a technology is its compatibility with 
phenotype detection assays. The neuro-chip described in this study, in 
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addition to the site-specific transfection of siRNA molecules, enables 
simultaneous assessment of a) neuronal morphology, b) specific proteins 
using fluorescent immunohistochemistry and c) electrical activity of single 
neurons and neuronal networks. The key challenges faced by the 
technology describe here towards realizing a high-throughput platform are 
the ability to deliver of multiple siRNA molecules and control over the 
dosage of delivery. Currently, the siRNA molecules are manually added to 
the wells prior to transfection. This will pose a major challenge in high-
throughput studies where hundreds of different siRNAs are to be 
transfected at different sites in the culture. This can potentially be 
overcome by incorporating mircofluidics with the MEA that would allow 
either serial or localized delivery of siRNA molecules. In another 
approach, different siRNAs can be spotted on the predetermined 
microelectrodes prior to cell seeding and the siRNAs then can be 
transferred into the cells sitting on the microelectrodes by reverse 
electroporation (Jain, Papas, Jadhav, McBride, & Saez, 2012; Yamauchi, 
Kato, & Iwata, 2004). In siRNA studies, one of the key factors that 
determine the level of target gene silencing is the number of siRNA 
molecules delivered to cells. The different turnover rates of different 
proteins require varying amounts of siRNA to achieve the same level of 
silencing. Additionally, a precise control over the level of gene silencing is 
highly desirable in gene interaction studies. The dosage of siRNA delivered 
to cells can be controlled to a certain extent by controlling the 
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concentration of the siRNA molecules in the electroporation buffer. 
Further control over siRNA dosage can potentially be established by either 
applying multiple pulses or performing repeated transfections. In either 
scenario, the time duration between multiple pulses and repeated 
transfections will have to be optimized to minimize cell death.  
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CHAPTER 5 
NANOCHANNELS TO ENHANCE CONSISTENCY OF TRANSFECTION 
EFFICIENCY 
 
5.1 Introduction 
Postmitotic cells, such as differentiated neurons, remain amongst 
the hardest cells to transfect. GFP transfection of neurons using 
microscale electroporation, as reported in chapter 4, displayed variable 
transfection efficiency. Transfection efficiencies per electrode in one MEA 
varied from 34% to 0%. Highly consistent and efficient transfection of 
genetic constructs is crucial in many neuronal cell biology experiments. 
Nanochannel based electroporation as demonstrated by Boukany et al. 
(2011) offers a promising approach for achieving highly efficient and 
consistent transfection (the work was demonstrated in chinese hamster 
ovary cells). In addition, the technique provides a precise control over the 
dosage of biomolecules delivered to cells, which is important in various 
genetic studies and therapeutic applications. In the above approach 
reported by Boukany et al. (2011), a setup comprising of two 
microchannels connected by a nanochannel (90 nm in diameter) (Figure 
22) is used for nanoscale electroporation of cells.   
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A single cell is positioned at the opening of the nanochannel in one of the 
microchannels. The other microchannel is filled with electroporation 
buffer containing biomolecules for transfection. An electric pulse is then 
applied by two wires placed in the microchannels causing transfection. 
High-intensity electric field generated at the end of the nanochannel 
electroporate a localized area on the membrane and biomolecules in the 
nanochannel are directly injected into the cell under the influence of the 
electric field. Major advantages of nanochannel based technique include, 
a) high cell viability due to electroporation of small area of the membrane, 
b) direct entry of the plasmids and siRNA into the cytoplasm from the 
nanochannel that lead to gene expression within 4 hours of transfection, 
and c) control over dosage by manipulating the pulse width and number.  
However, a major area of improvement in the technique developed by 
Boukany et al. (2011) is the experimental throughput; currently, the 
technique only allows electroporation of one cell at a time and requires 
manual manipulation of the cell next to the channel. In another approach, 
Fei et al. (2007) demonstrated electroporation of cells trapped between 
two membranes (Fei et al., 2007). However, both of the above mentioned 
techniques are not compatible with situ experiments in adherent cell 
cultures. 
 This study investigated the use of nano-porous alumina membrane 
in tandem with MEA for achieving site-specific nanochannel based 
electroporation in adherent cells (Figure 23). It is hypothesized that the 
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integration of the MEA with nanochannels will provide a high-throughput 
method for transfecting cells with efficiency and consistency offered by 
nanochannel electroporation. The nano-sized pores (200 nm) in the 
alumina membrane act as nano-channels (Figure 23(a)) that can 
potentially electroporate small area of cell membrane. This study aims to 
demonstrate proof-of-concept of the integrated approach by 
electroporating HeLa cells cultured on alumina membrane with an MEA 
placed underneath the alumina membrane (Figure 23(a)).  
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 (a) 
 
(b) 
Figure 23. Schematic of electroporation scheme integrating the MEA with 
a nano-porous membrane. (a) A schematic of cell culture onalumina 
membrane with nanopores. The MEA placed under the nanoporous 
membrane generate the electric field for electroporation. (b) A schematic 
showing the steps for electroporation.  
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5.2 Materials and methods 
 
5.2.1 Cell culture on nanoporous membranes 
Alumina membranes used in this study were purchased from 
Whatman Ltd. (Anodisc 13). The membranes were 60 µm thick and the 
pores in the membrane were 200 nm in diameter. Small glass wells with 1 
cm diameter were bonded on the alumina membranes to contain the cell 
media. 24-48 hours prior to electroporation experiments, HeLa cells were 
seeded on the alumina membranes in 200 µL of cell media. The cell 
cultures were stored in 37°C humidified incubator.  
 
5.2.2 Electrical characterization 
The electrical characterization of the microelectrodes was 
conducted using an electrochemical workstation (Model 660a, CH 
instruments, TX, USA). The electrical impedance spectroscopy (EIS) was 
carried out for a frequency sweep of 100 Hz -100,000 Hz. Cyclic 
voltammetry (CV) was conducted for -1.5 V to 1.5 V.  For the EIS and CV 
experiments, a 30 µL drop of phosphate buffered solution was placed on 
the MEA. Following which, an alumina membrane with a glass well, 
containing PBS, was placed on the MEA, sandwiching the drop of PBS on 
MEA. A platinum wire was placed in the glass well with PBS acted as a 
reference and counter electrode.  
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5.2.3 Electric field simulations 
 FEM simulations of electric field were carried out in COMSOL v3.5. 
For the FEM simulations, a 2D model representing an electrode with 
nanomembrane on it was created. The pores in the membrane act as 
individual nano-channels with 200 nm diameter width and 60 µm length. 
The model was solved using finite element analysis, as described in 
chapter 3, to simulate the electric field intensity distribution at the end of 
the nanochannel.  
 
5.2.4 Electroporation and imaging 
Prior to electroporation experiment, 300 µL of 30 µg/ml PI solution 
in ice cold electroporation buffer and 300 µL of 4 µM calcien AM solution 
in PBS was prepared. Immediately before electroporation, a 30 µL drop of 
electroporation buffer with PI was placed on the MEA (Figure 23 (b)). 
Subsequently, the alumina membrane with HeLa cell culture was placed 
on top of the MEA; sandwiching the drop of electroporation buffer with PI 
between the MEA and the alumina membrane. The MEA and the alumina 
assembly was then placed in the incubator for five minutes to allow 
diffusion of PI into the nanochannels. Thereafter, the media in the well on 
the alumina membrane was replaced with electroporation buffer with PI. 
Single square anodic pulses with duration of 1 msec were applied to the 
microelectrodes for electroporation with a ground electrode placed in the 
well. After the pulse application, the MEA assembly was immediately 
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placed in the incubator. The cells were allowed to incubate for 10 mins 
before replacing the electroporation buffer in the well with media to 
provide time for the cell membrane resealing.  
 A live assay was performed 2 hours after the electroporation 
experiments to assess the viability of the cells. Images were captured and 
analyzed in image j.  
 
5.3 Results 
 
5.3.1 Electrical characterization 
 EIS and CV were performed to assess the changes in the electrode-
electrolyte interface in the presence of the alumina membrane. Figure 24 
shows the plot of EIS and CV results for the MEA with and without the 
alumina membrane. As seen in Figure 24, the shape of CV remained 
unaltered by the presence of the nanoporous membrane. In addition, the 
impedance measurements of the electrode-electrolyte interface also 
indicated no significant change. 
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Figure24. CV (a) and EIS (b) with the nanoporous membrane on the MEA.   
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5.3.2 Electric field simulation 
 The simulation of the electric field intensity at the end of the 
nanochannel showed presence of very high fields at the corners of the 
nanochannels (Figure 25), similar to FE simulation of microelectrodes 
(chapter 3). At the center of the nanochannels the electric field intensities 
decreased by more than 2.5 times. Simulation of electric field intensity for 
four neighboring nanochannels showed electric field interactions between 
neighboring nanochannels. The electric field intensities at the surface of 
the nanoporous membrane remained similar to single channel simulation 
with high intensities at the corners of the nanochannels and low at the 
center at of nanochannels. However, at height of 500 nm above the surface 
of the nanochannels, the interaction of electric field between neighboring 
channels led to a more uniform distribution of the electric field. It is likely 
that cells experience electroporation on the membrane facing the 
nanochannels as well as on the side of the membrane facing the ground 
electrode.  
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Figure 25. Simulation of electric field intensities for the nanochannels. (a) 
Electric field intensity at the opening of the 200 nm channel at 10 V. (b) 
Left is shown electric field simulation for four 200nm channels (spacing of 
200nm) at the opening of the opening. Right shows the electric field 
simulation at a height of 500 nm above the channel opening.   
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5.3.3 Electroporation  
 HeLa cells cultured on the nanoporous membranes were 
electroporated in the presence of PI at different pulse amplitudes (15 V – 
50 V) with fixed pulse duration of 10 msec to evaluate electroporation 
efficiency and viability. Figure 26 shows image of cells on nanoporous 
membranes after electroporation. Successfully electroporated cells stained 
red due to entry of PI and live assay stained cells green. At high voltage 
electroporation pulses (50 V) cell fusion was a common observation 
(Figure 26).  Total percent of cells electroporated and cell viabilities at 
electroporation pulses of 15, 20 and 25 V is shown in Figure 27.  
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Figure 26. Electroporation and viability results for electroporation pulse of 
amplitudes 15, 20, 25 and 50 V (10 msec) on the nanoporous membrane. 
The white arrow points to cell fusion observed at the 50 V pulse. The scale 
bars are 100 µm.  
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Figure 27. Percentage of cell Electroporated and viability plot for 15, 20 
and 25 V electric pulses with a fixed width of 10 msec. 
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5.4 Discussion and conclusion 
This study demonstrated successful targeted electroporation of cells 
cultured on a nanoporous membrane by manipulating electric field 
intensities associated with MEA placed under the membrane.  The nano 
sized pores in the alumina membranes act as nanochannels and allowed 
electroporation of the cell adhered on the membrane.  It is likely that the 
number of sites on cell membrane that get electroporated depends on the 
density of nanopores present in alumina membrane, which might 
influence cell viability; high density of nanopores might cause irreversible 
damage to the cell membrane upon electroporation. The electroporation 
parameters need to be further optimized for both electric pulse amplitude 
and duration to realize the highest transfection efficiency in neurons and 
to determine if alumina membrane based method offers significant 
enhancement in transfection efficiency in comparison to microscale 
electroporation. It also remains to be tested if the dosage of genetic 
constructs delivered to cells using the alumina membrane method can be 
controlled by pulse amplitude and duration, as demonstrated by Boukany 
et al. (2011) in nanochannel electroporation.  
The EIS and CV measurements indicate that it is possible to record 
electrical activity of neurons cultured on the nanoporous membranes 
through an MEA placed under the membrane, however, this remains to be 
experimentally tested. Since the alumina membrane is likely to be 
separated from the ITO electrodes by at least few hundred microns (Figure 
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23(a)) cells might suffer less damage from electrolysis that takes place at 
the electrode-electrolyte interface for the duration of the electric pulse. 
Further development and validation of this technology may provide a 
novel approach for achieving highly efficient transfection with precise 
dosage control in primary neuronal cultures.  
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CHAPTER 6 
CONCLUSION AND FUTURE WORK 
 
6.1 Spatially and temporally controlled transfection in a secondary cell line 
This work in this dissertation reports the fabrication of a fully 
transparent MEA for targeted transfection in adherent primary and 
secondary cell lines using microscale electroporation.  The ITO based MEA 
with parylene insulation provided a transparent and biocompatible 
substrate for cell growth. A critical requirement of technologies that enable 
gene manipulation is to be able to assess the resulting phenotype. The 
compatibility of the ITO based MEA with standard imaging equipment 
was crucial in bio-imaging assays. In the current state, cells on the MEA 
can be imaged at a maximum magnification of 400X (40X objective). In 
applications that desire higher magnification, for detailed analysis of sub-
cellular phenotypes, the thickness of the glass substrate can be further 
reduced to less than 200 µm using microfabrication techniques.  
The technology developed here allowed rapid optimization of 
electroporation parameters which were used for delivery of siRNA and 
GFP. The optimization of electroporation parameters is often a time-
consuming and tedious process and the parameters need to be separately 
optimized for each cell type. The protocol developed in this work provides 
detailed steps for using any custom-made or commercially available MEA 
for site-specific transfection in cells and is independent of the cell type. 
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The protocol was described for use in a typical lab, equipped for cell 
culture, without the need of any specialized equipment. The strength of the 
microarray based approach lies in the ability to perform multiple 
experiments on the same culture, as demonstrated in this work, thereby 
increasing the experimental throughput and decreasing culture-to-culture 
variability. Another advantage of using MEA for microscale 
electroporation is the ability to create different patterns and sizes of 
electrodes which directly control the target area and target locations in the 
culture. However, the electroporation experiments with electrodes of three 
different sizes and finite element simulation of the associated electric field 
showed that the electroporation efficiency decreases with increase in 
electrode size (>100 µm in diameter) due to the non-uniform electric field 
distribution on large diameter electrodes. This knowledge is extremely 
useful in developing future platforms for applications that may require 
large populations of cells to be transfected per site. In such a scenario, 
multiple small electrodes could be patterned close to each other allowing 
transfection of larger population of cells within a culture.  
In this work, successful delivery payloads of different sizes (PI, 
siRNA and plasmid vector) to precisely targeted locations in a HeLa cell 
culture using microscale electroporation was demonstrated. The use of 
microscale electroporation resulted in efficient and consistent gene 
silencing and gene expression in targeted cells. In addition, the platform 
developed in this study also allowed for in-situ assessment of the response 
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of cells to microscale electroporation. The temporal analysis of actin 
disruption and reorganization in response to electroporation demonstrate 
the applicability of this technology in assessment of sub-cellular 
phenotypes. The ITO based MEA described in this study is a readily 
scalable platform and further development of this technology will provide 
a cost-effective high-throughput approach for genetic screens.  
 
6.2 Targeted transfection and simultaneous electrophysiological 
assessment in primary neurons 
A major obstacle in genetic studies involving primary neurons has 
been the difficulty to efficiently transfect them. In this study, the use of 
MEA for targeted delivery of genetic payloads of different sizes and 
characteristics (PI, siRNA and GFP) to hippocampal neurons in culture 
has been demonstrated for the first time. In addition, the patterned 
microelectrodes were used to measure spontaneous electrical activity of 
neurons in response to electroporation. The technology described in this 
study offers a powerful tool for investigating cell-cell interactions. Delivery 
of genetic constructs to targeted neurons in a network would allow 
functional electrophysiological assessment of the impact of gene 
manipulation on targeted neurons and the entire network behavior in real 
time. In addition, this study demonstrated successful delivery of GFP 
plasmid vectors through microscale electroporation of neuronal processes. 
This opens the possibility of delivering genetic construct to neurons with 
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remotely located cell bodies by localized electroporation of axons 
(currently done by viral vectors). In addition, delivery of siRNA directly to 
axons would enable localized inhibition of genes involved in synapse 
formation, axonal growth and transport.  
 
6.3 Nanochannels based high-throughput transfection 
 A major limitation with neuronal studies in low and inconsistent 
transfection efficiencies associated with majority of the current 
transfection methods. In this study, the use of nanoporous membrane in 
tandem with MEA to achieve nanochannel electroporation in adherent 
cells was evaluated. Nanochannel electroporation has been demonstrated 
to offer highly consistent and efficient transfection with precise dosage 
control (Boukany et al., 2011). In this study, HeLa cells cultured on a 
nanomembrane were electroporated to demonstrate the proof-of-concept.  
In addition, the electrical characterization of the results of the nano-
membrane and MEA assembly suggest the possibility of measuring the 
electrical activity of neurons. Further development and validation of this 
technology may provide a novel approach for achieving highly efficient 
transfection with precise dosage control in primary neuronal cultures. 
 
6.4 Limitations  
An extremely important element of the genetic screens is the 
development of appropriate phenotypical assays. The technology 
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described in this work allows electrophysiological assessment of neurons 
in real time along with the assessment of neuronal morphology and 
protein levels using fluorescent immunohistochemistry. However, it 
presents a major challenge in the extraction of modified cells for further 
extensive analysis of gene expression levels with techniques such as PCR, 
DNA microarrays and western blotting. One of the approaches to 
overcome this limitation is to fabricate customized stencils that would 
allow selective trypsinization and extraction of cells only from the 
electrodes. Another approach would be to implement in situ PCR for 
detection of specific RNA transcript levels (Bagasra, 2007).  
In this work, successful delivery of functional siRNA to targeted HeLa cells 
has been demonstrated. However, a variable with very limited control was 
the dosage of the siRNA delivered to cells. siRNAs achieve only a partial 
knock down of the target gene and the level of knock down is a function of 
the concentration of the siRNA in the cells (D. H. Kim & Rossi, 2008) . 
Thus, in siRNA based studies, it is extremely desirable to maintain a 
precise control over the dosage of siRNA delivered to cells. There are 
several strategies that could be employed to overcome this limitation. For 
instance, the use of nanochannel for electroporation has previously 
demonstrated precise control over dosage of siRNA delivered to cells 
(Boukany et al., 2011), which has been one of the motivations behind us 
investigating the use of nanochannel template in site-specific transfection. 
Another approach includes repeated electroporation of cells at different 
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time points to increase the siRNA concentration levels in the cells, which 
would also enable subsequent delivery of different siRNAs. A key variable 
here that would need optimization is the time between subsequent 
electroporations for maximizing viability.   
Another limitation with the current MEA based system is the large amount 
of siRNA needed for transfection (400 µl of 1µM siRNA), which is very 
high compared to conventional chemical transfection based approaches 
and thus limits the cost effectiveness of the system (Patel & Muthuswamy, 
2012). This can partly be overcome by incorporating mircofluidics with the 
MEA based system to decrease the total volume of siRNA electroporation 
solution to less than a few microliters, as described in the following 
sections. Additionally, the microfluidics can enable serial delivery of 
different siRNA molecules; thereby greatly enhancing the throughput of 
the MEA based technology. Alternatively, siRNA molecules can be spotted 
on the microelectrodes prior to cell seeding, after which the siRNA 
molecules can be transfected into cells by reverse electroporation (Jain, 
Papas, Jadhav, McBride, & Saez, 2012; Yamauchi, Kato, & Iwata, 2004). 
 
6.5 Future directions  
RNAi offers a powerful method for elucidating gene function in a 
high-throughput fashion; especially in a post genome sequencing era that 
has led to the discovery of hundreds of thousands of genes with unknown 
function. The technique of RNAi offers a unified approach for both 
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discovering therapeutic genetic targets and as a therapeutic agent. In the 
recent years, siRNA have been the focus of many clinical studies (Burnett, 
Rossi, & Tiemann, 2011). In this study, a scalable technology for localized 
transfection in primary neurons is presented. The technology developed in 
this work can be extended in two parallel directions with the ultimate 
motivation of providing a therapeutic strategy for CNS disorders. These 
two directions are discussed in the following sub-sections. 
 
6.5.1 High-throughput and high content screening in vitro 
An example of the design of a scaled-up version of the nanochannel 
based MEA system for high-throughput screening (HTS) is shown in 
Figure 28. In this approach, microwells can be patterned on the 
nanochannel template to restrict neuronal populations in microwells. 
MEAs patterned beneath each well would allow independent transfection 
of neurons within each well. Microfluidic channels can be patterned in 
between the nanochannel template and MEAs for individual delivery of 
genetic reagents to each well in nanoliter volumes. The advantages of such 
a system would be the cost-effectiveness and the consistent delivery of 
genetic constructs to neurons. In addition, the MEA present in each well 
can be used for measuring the electrical activity of neurons.  
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Figure 28. The above schematic describes a hypothesized nanochannel 
electroporation based biochip for HTS. 
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The key steps for the design of high-throughput screens (HTS) include a) 
clear definition of the goal of the screen, b) selection of appropriate 
phenotypical assays, c) a clearly defined metric for assessment and scoring 
of phenotypes, d) a well-defined criteria for selection of hits and e) 
secondary validation screens to identify the biologically significant hits 
(Boutros & Ahringer, 2008). A major limitation with the current HTS for 
neuronal studies has been the lack of ability to measure the electrical 
activity of neurons in a high-throughput fashion in real time, which is an 
important phenotypical assay in neuronal studies. MEA based systems 
offer unique advantage of simultaneous multiple phenotype assessment in 
neurons including electrophysiological assessment, thereby greatly 
enhancing identification of key players and relationships in signaling 
pathways in neurons. Another significant area for advancement in HTS is 
high content screening, as it generates data rich in information. For 
example, in axonal outgrowth studies, GFP expressing primary neurons 
can be screened against a library of siRNA molecules to identify genes 
involved in axonal outgrowth (Sepp et al., 2008). In such a study, GFP 
expressing primary neurons harvested from embryonic Day 18 rat could be 
grown in microwells of a high-throughput MEA based system (Figure 28).  
Subsequently, the MEA present within each well could be used for 
electroporating neurons in different wells with different siRNA, followed 
by monitoring of the electrical activity of neurons. The process of the 
axonal growth of neurons in different microwells can then be captured in 
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real time by fluorescent imaging as the neurons mature, fully differentiate 
and become electrically active. The obtained images and electrical activity 
data can then be analyzed and quantified with automated scripts to 
identify genes involved in axonal outgrowth. A major advantage of MEA 
based systems here would be the ability to draw connections between the 
genes involved in axonal growth and the molecular pathways underlying 
the onset of electrical activity in maturing neurons and synapse formation 
in a high-throughput and cost-effective manner.  
 
6.5.2 Localized transfection in the brain 
Neural circuitry in the brain is very complex in nature with each neuron 
making approximately 5,000 to 200,000 connections with other neurons. 
There are more than 10,000 types of neurons, which are spaced very close 
to each other. Neurons that are near each other may be involved in 
completely different circuits and have completely different functions. Any 
technique that aims to intervene at the neural circuit or individual neuron 
level needs to have precise spatial control over delivery(L. Luo, Callaway, 
& Svoboda, 2008) . The target area generally may be in micrometers; 
hence an accurate system with a precise delivery mechanism is absolutely 
essential. A potential direction of future work would involve translation of 
the work described herein to in vivo. Such a technique would allow precise 
localized silencing and expression in the brain; thereby enabling 
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investigation of neural circuit function and evaluation of therapeutic 
strategies. 
A neural probe can be fabricated using a standard MEMS process. 
Figure 29 shows the example of a hypothetical neural probe for targeted 
transfection in CNS. A microfluidic channel fabricated in the probe would 
allow delivery of genetic reagents in the targeted area. Subsequently, 
electric fields associated with the microelectrodes, which are patterned on 
the neural probe, can be manipulated to electroporate desired regions in 
the brain. 
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Figure 29. The above figure shows a hypothesized neural probe for 
targeted electroporation in the brain. The microelectrodes would generate 
the electric field necessary for electroporation and the microfluidic 
channel would deliver the biomolecules for transfection.  
  
Microelectrodes 
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Below: Complete photolithography process for the biochip fabrication  
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APPENDIX B  
EP PARAMETER OPTIMIZATION 
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Below: Electroporaiton pulse voltage optimization HeLa cell for 1 msec 
duration pulse. 
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Below: Site-specific delivery of PI to HeLa cells for an 8 V, 1 msec pulse on 
a 100 µm diameter electrode. The image on the left shows the cells on the 
electrode fluorescing red due to the uptake of PI. The image on the right is 
a superimposed image of PI and live assay. The white circle marks the 
boundary of the electrode. 
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APPENDIX C 
NEURAL ACTIVITY AFTER GLUTAMATE STIMULATION 
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Below: Neural activity recording before and after glutamate addition. 
Neural activity was recorded for 10 mins before and after addition of 
glutamate to cells. Neural recording from 23 channels with activity was 
sorted to identify individual units in each channel. The data shows an 
increase in the number of units in 14 out 23 channels. 
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